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ABSTRACT OF THE DISSERTATION
Effect of Maternal Hypoxia on Fetal Development: Programming of
HIE Phenotype in Neonatal Rat Brain
by
Pablo J González-Rodríguez
Doctor of Philosophy, Graduate Program in Biochemistry
Loma Linda University, June 2014
Dr. Lubo Zhang, Chairperson

Developmental programming of health and disease correlates the adverse
intrauterine environment and the risk of disease later in life as cardiovascular disease,
metabolic diseases, renal dysfunction or neurobehavioral disorders among others.
Maternal hypoxia is one of the most common intrauterine growth restricted environment
during pregnancy. Perinatal hypoxic-ischemic encephalopathy is an important cause of
brain injury in the newborn due to a systematic asphyxia. Our study aims to test the
hypothesis that maternal hypoxia affect the organogenesis of the kidney by affecting the
kidney structure and focusing on the roles of AT1R and AT2R, while the brain
development will also be affected by this maternal insult increasing the vulnerability of
this to HIE brain injury and the role of GR and the epigenetic modification that regulate
the expression of the GR will be assessed. Finally, the MAPK/ERK pathway as part of
the downstream of the neuroprotective mechanism of the GR against neonate HIE brain
injury will be evaluated. To address these issues two rats model were established:
perinatal hypoxia exposure model in time-dated pregnant rats and hypoxic-ischemic
encephalopathy in 10-day-old rat pups. Through these studies we found that maternal
hypoxia decrease the number of glomeruli in offspring rat kidneys and a down-regulation
on the expression of AT1R was observed in the kidneys of the adult rats in a sex

xv

dimorphism way, affecting more the females than the males. In addition, we observed
that maternal hypoxia increased the vulnerability of the brain to HIE on P-10 pups by
repressing the expression of GR. Epigenetics studies demonstrated that this downregulation of GR was due to hypermethylation on promoter region of exon variants 17
and 111 of the GR gene. Dexamethasone, a synthetic glucocorticoid, treatment on
normoxic P-10 brains increased the expression of LPGDS, and pERK44 and also the
level of prostaglandin D2, while, the neuroprotective effect of dexamethasone observed
against HIE brain injury on P-10 pups was diminished by MAPK/ERK and LPGDS
inhibitor, and by blocking the DP1 receptor. These findings provide a new insight in
understanding the pathogenesis of HIE in newborns and may suggest potential targets for
the prevention and treatment of HIE brain injury.
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CHAPTER ONE
INTRODUCTION

Programing Diseases
Adverse fetal environment, mostly manifested as intrauterine growth restriction
(IUGR), contribute to affect organogenesis and furthermore, may affect organ function at
maturity increasing the probability for an individual to have a variety of health problems
such as coronary heart disease, type 2 diabetes, neurobehavioral disorders, hypertension,
cardiovascular disease, or renal dysfunction among others (Dudley, Li, Kobor, Kippin, &
Bredy, 2011; Harris & Seckl, 2011). This adverse insult during fetal development may
lead to low birth weight, which is a common marker of IUGR in the offspring. The
hypothesis of ‘‘developmental programming of health and disease’’ or ‘‘fetal origins of
adult disease’’ was put forward to elucidate these links between adverse intrauterine
environment, fetal growth and development, and disease later in life.
Environmental signals can be transmitted from the mother to the fetus, impacting
specific vulnerable tissues in their sensitive developmental stage, modulating normal
development trajectory, remodeling their structure and function and reprogramming the
resiliency or susceptibility to diseases in postnatal life.
Plenty of studies, using different maternal perturbation, have demonstrated a
significant effect on the organogenesis due to those adverse environments. Malnutrition
is one of the most common that may contribute to perinatal programming, and both ends
have been extensively studied, from undernutrition (caloric and protein restriction diets or
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low-vitamin intake) (Erkkola, Nwaru, & Viljakainen, 2011; Mackay, Khazall, Patterson,
Wellman, & Abizaid, 2013; Woods, Ingelfinger, Nyengaard, & Rasch, 2001) to
overnutrition (high-fat, high-energy and high-protein diets) (Elahi et al., 2009; Gniuli et
al., 2008; Oster, Murani, Metges, Ponsuksili, & Wimmers, 2012). Another environmental
stress for fetal development is maternal smoking. It is estimated that approximately 22%
of pregnant mothers smoke during the gestational period (Nelson & Taylor, 2001). The
use of nicotine during pregnancy has been reported to affect the organogenesis of the
brain (Bruin, Gerstein, & Holloway, 2010) and the heart (Xiao, Huang, Yang, & Zhang,
2011) and eventually it affects the function of these organs during adulthood. Brain and
cardiovascular programming diseases also occurred when the fetus is exposed to cocaine
(Gressens, Mesples, Sahir, Marret, & Sola, 2001; Xiao, Huang, Xu, Yang, & Zhang,
2009). Plenty of evidence has demonstrated that fetal stress induces an abnormal
development of organs and could program them to be more vulnerable to some kind of
disease or condition later in life.

Kidney Development
The “developmental programming of health and disease” hypothesis has been
extended to other adult diseases as lung function, (Stein et al., 1997) learning ability
(Strang-Karlsson et al., 2008), immune function (McDade, Beck, Kuzawa, & Adair,
2001) and also renal function (Manalich, Reyes, Herrera, Melendi, & Fundora, 2000).
One of the most important functions of the kidney is to filtrate urine by small structures
called nephrons. A human kidney contains an average ~ 1 million nephrons, but the range
in normal human population varies considerably (Hughson, Douglas-Denton, Bertram, &
Hoy, 2006). Hypertension is one of the most common diseases associated with fetal
2

programing. It has been hypothesized that high risk for hypertension is due to a
congenital deficiency in the number of nephrons, which results in a reduction of the
filtration surface area that programs a subsequent reduction in glomerular filtration rate.
This reduction in GFR will lead to an increase in sodium retention and eventually
hypertension (Mackenzie & Brenner, 1995). Human and animal studies of low birth
weight newborns demonstrate a reduced glomerular number. Thus, the process and
consequence of reduced intrauterine growth is sufficient to impair renal development.
Furthermore, a reduction in the nephron number and an increase blood pressure on the
offspring has been reported in studies using different maternal adverse environment such
as low protein diet (Woods et al., 2001), glucocorticoids (Ortiz, Quan, Zarzar, Weinberg,
& Baum, 2003), placenta insufficiency (Wlodek, Westcott, Siebel, Owens, & Moritz,
2008) and maternal sodium overload (Koleganova et al., 2011).
In rats, the second half of gestation is a critical period for renal development
because nephrogenesis process is during this time; being the late renal development
period, the most susceptible due to the nephron number increasing exponentially at this
time. Therefore, any kind of fetal adverse environment during nephrogenesis will induce
an impairment renal development that cannot be restored later in gestation, even if the
adverse environment is removed (O'Sullivan et al., 2013; Singh et al., 2007).
The renin angiotensin system has been associated in certain of these program
outcomes. It is known that RAS is often repressed during renal development, potentially
contributing to the nephron deficit, followed by a compensatory increase in activity in
postnatal life (Moritz et al., 2010). Given the essential function of the RAS in fluid
balance and blood pressure control in the adult, long-term up-regulation of this system,
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combined with the low nephron endowment, provides a highly plausible pathway through
which prenatal insults may result in hypertension.

Brain Development
The brain is one of the critical targets of stressors and is also the central organ
responsible for stress responses, determining the adaptive or maladaptive responsiveness
to various acute and chronic stressful events via making corresponding alterations in its
structure and function (McEwen, 2008). The developing brain in the fetal stage is also
highly plastic, flexible, and especially sensitive to numerous adverse environmental
factors. Combined with its specific genetic traits, these changes of fetal brain contribute
to a high incidence of a wide spectrum of neurodevelopmental disorders in the postnatal
life. It has been well documented that fetal stresses, such as hypoxia, malnutrition,
substances exposure (nicotine, alcohol and cocaine) and excess glucocorticoids
(endogenous or exogenous), have long lasting impact on the developing brain; altering
brain’s ontogeny, organization, structure and function; remodeling brain’s development
trajectory, and reprogramming brain’s vulnerability or resiliency of some
neurobehavioral, neuropsychological and neuropsychiatric disorders later in life (Harris
& Seckl, 2011).
It is known that the last week of gestation for mice and rats, where fetal brain
development is taking place, is parallel with the first-second trimester of human fetal
development and the development of the rat brain during the first two postnatal weeks are
parallel with the third trimester in human fetal brain (Golan & Huleihel, 2006). Animal
studies have provided evidence linking maternal adverse environment and the increased
incidence of neurodevelopmental disorders, neurobehavioral deficits, impaired cognitive
4

performance, and increased risk of affective disorders later in life (Y. Li et al., 2012;
Maier, Chen, Miller, & West, 1997).

Maternal Hypoxia
Another common hostile environment associated with IUGR is maternal hypoxia,
which is a reduced level of oxygen during pregnancy; this is one of the most significant
challenges facing obstetric clinic practice. There are various possible scenarios, which
could induce a hypoxia environment to the fetus. Fetal hypoxia is very common in
pregnant women that live at high altitude; also, unfortunately, many pregnant women
continue to smoke during pregnancy, as was mentioned before, exposing the fetus to
prolonged hypoxemia. Furthermore, the placenta plays a very important and critical role
in fetal development because the placenta helps to exchange oxygen, nutrients and waste
between the mother and the offspring, therefore, if the mother has any kind of conditions
that could affect this process as anemia, preeclampsia, or heart and lung disease this
could result in a diminished of pO2 that may lead the fetus to experience hypoxia.
Fetal hypoxia results in a decrease of amniotic fluid production and a
redistribution of fetal blood flow away from peripheral circulation, but an increase of
perfusion to the brain, heart and liver (Richardson & Bocking, 1998). Although this
redistribution can lead to fetal survival, this experience of adaptation can produce an
increased risk of some health condition in adulthood. In animal models it has been
reported that maternal hypoxia affects the organogenesis of brain (Northington, Ferriero,
Flock, & Martin, 2001) and heart (G. Li et al., 2003; Patterson, Chen, Xue, Xiao, &
Zhang, 2010). In the brain, the most vulnerable regions to hypoxic insult are the cerebral
cortex, hippocampus and sub-ventricular zone (Northington, Ferriero, Graham,
5

Traystman, & Martin, 2001). In the hippocampus it was reported that a hypoxic
environment induced neuronal death in the CA1 and that cytosolic phospholipase A2
activity plays and important role in the neuronal degeneration mechanism (Arai et al.,
2001). Also, inflammation could play a very important role in the mechanism associated
with fetal brain injury due to maternal hypoxia. Recently, it was reported that chronic
hypoxia exposure induced an increase in the lactate:pyruvate ratio and a decrease in the
GSH:GSSG ratio, a favorable pro-oxidant state, and also that the expression levels of
Bax, Dcl-2 and p53, which are pro-apoptotic proteins, as well as the levels of some proinflammatory cytokines were increased (Guo et al., 2010). In the heart, maternal hypoxia
induced atypical expression of important genes that results in modification of the heart
structure and function. The expression of PKC was down-regulate, while the angiotensin
II type 2 receptor was up-regulate in the developing heart due to maternal hypoxia,
increasing the sensitivity to cardiac ischemic injury in the offspring (Patterson et al.,
2010; Xue, Dasgupta, Chen, & Zhang, 2011).

Epigenetics
During fetal development different events occur in a way to repress or activate
gene transcription via epigenetic mechanisms. Epigenetic control of gene expression
involves modification of the genome without altering the DNA sequence itself. The
chromatin-based epigenetic is very important to ensure the correct integration of
developmental signals at gene regulatory regions in which chromatin modifications play
very important roles. Some of these chromatin modifications are mediated by DNA
methylation and histone posttranslational modifications, including histone methylation,
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acetylation, phosphorylation, ubiquitylation, sumoylation and propionylation (Jungel,
Ospelt, & Gay, 2010; Ouvry-Patat & Schey, 2007). Animal studies have demonstrated
the importance of epigenetic changes in mediating the effects on adult phenotype and
physiology arising from perturbations of the developmental environment, including
maternal diet (Lillycrop, Phillips, Jackson, Hanson, & Burdge, 2005; Waterland & Jirtle,
2003), uterine blood flow (Pham et al., 2003), and maternal nursing behavior (Weaver et
al., 2004).
For example, it has been reported that a maternal low-protein diet induced a
hypomethylation in the gene promoter region of ACE-1 in the fetal brain (Goyal, Goyal,
Leitzke, Gheorghe, & Longo, 2010); likewise the same diet decreased the methylation
levels of exon 110 at glucocorticoids receptor gene promoter and also affect the
expression of DNA methyl transferase 1 resultant in an increased expression of GR in the
offspring (Lillycrop et al., 2007). Also, it is known that PKC plays a very important role
in cardioprotection during cardiac ischemia and reperfusion injury, however fetal stress in
animal models such as hypoxia, nicotine or cocaine exposure resulted in a repression of
the PKC gene in the developing heart causing an increase heart vulnerability to ischemia
and reperfusion injuries in the offspring, suggesting a common mechanism of PKC in
fetal programming of heart disease during adulthood (Meyer, Zhang, & Zhang, 2009;
Patterson et al., 2010). Moreover, epigenetic regulation has been associated with
programming of type 2 diabetes mellitus. In a recent study, where islets were isolated
from fetuses exposed previously to IUGR, it was demonstrated that histone acetylation in
H3 and H4 at the proximal promoter Pdx1, which plays a critical role in the development
of the endocrine and exocrine pancreas, was decreased (S. W. Park et al., 2008). This
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modification affected the binding of USF1, an activator of Pdx1, and the resulting
repression of Pdx1 transcription induced the aberrant development of the pancreas (H. Li
et al., 2006).
As we can see, the effects on the offspring of epigenetic changes during
development in animals mimic aspects of human disease, for example, metabolic disease,
cardiovascular condition, or neurobiological function, and a coherent theory for a role of
epigenetic mechanisms in the developmental origins of later chronic disease is emerging.

Hypoxic-ischemic Encephalopathy
One of the most common causes of neonatal brain damage is hypoxic-ischemic
encephalopathy due to a systematic asphyxia, which may occur prior, during or after birth
(Douglas-Escobar & Weiss, 2012). Epidemiological studies have demonstrated that one
to three per 100 live full-term babies will experience HIE, where 15%-20% of them will
die in the post natal period and 25% will develop neurological deficits and long-term
neurodevelopmental disabilities in later life including, mental retardation, visual motor
dysfunction, cerebral palsy and epilepsy (Vannucci & Perlman, 1997). A neonatal animal
model for HIE has been developed to mimic this human condition and study the
pathophysiology of perinatal HIE which is difficult to perform in a human. This model is
known as the Vannucci model in which 7-day postnatal rats experienced a unilateral
common carotid ligation followed by systemic hypoxia in 8% oxygen balanced with
nitrogen environment (Vannucci et al., 1999). This insult produces permanent hypoxicischemic brain damage limited to the cerebral hemisphere ipsilateral to the carotid artery
occlusion. Despite the advances in the last two decades in research of cellular processes
and molecular mechanism underlying HIE, hypothermia is the only effective treatment
8

for full-term newborns with mild or moderate HIE, however this treatment has some
limitations. The use of the HIE model in this study will help us to evaluate the effect of
adverse fetal environment on brain programming disease and also to evaluate possible
neuroprotective mechanisms against HIE.

Glucocorticoids
Glucocorticoids are essential for life and play a crucial role in the regulation of
growth and development, but also are implicated in various pathogenesis. The
glucocorticoids exert their action by binding with different affinity to two receptors, the
glucocorticoid and the mineralcorticoid receptor. Interestingly, antagonist effects have
been associated with the glucocorticoids, where a neuroprotective and neurodegenerative
effect has been reported (Abraham, Harkany, Horvath, & Luiten, 2001). The
neurodegenerative effect has been found for long-term exposure and high levels of
glucocorticoids while the neuroprotective effect has been observed for physiological
levels of glucocorticoids. Also, glucocorticoid receptor has been affected by IUGR,
studies with prenatal undernutrition resulting in a decreased expression of hypothalamic
glucocorticoid receptors in rats, increasing the risk of hypertension later in life (Perez et
al., 2010). In addition, maternal nicotine exposure decreases the mRNA expression levels
of hippocampal GR in the offspring (Liu et al., 2012). The neuroprotective role of the
glucocorticoid receptors was demonstrated when adult rat brains were pretreated with
dexamethasone, a synthetic glucocorticoid, and a reduction of infarct volume after focal
cerebral ischemia was observed (Feng, Rhodes, & Bhatt, 2011). A better understanding
of molecular mechanisms of neuroprotection by dexamethasone may provide a basis for
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the development of newer therapeutic strategies involving corticosteroids or other novel
compounds for the prevention and treatment of HI brain injury.

Prostaglandin
Prostaglandin D2 is the most abundant prostaglandin in the brain, a metabolite
from arachidonic acid. This PGD2 accumulates in the cerebrospinal fluid, where it
induces physiologic sleep in rats and humans. Recently it was reported that PGD2
protects neonatal mouse brain from HI injury (Taniguchi et al., 2007). Also, in-vitro
studies using rodent neuronal cells demonstrated that dexamethasone stimulates the gene
expression of the 26 kDa glutathione-independent L-PGDS the enzyme responsible for
the production of prostaglandin D2 (Garcia-Fernandez et al., 2000). Recent studies
demonstrated that PGD2 elicits its downstream effects by activating two G proteincoupled receptors; the DP and chemoattractant receptor-homologous molecule expressed
on Th2 cells receptors (hereafter termed DP1 and DP2) where DP1 is coupled to Gαs and
DP2 is coupled to Gαi. Interestingly, these two receptors have divergent effects on cAMP
production, when BW245C, a DP1 agonist, is added to hippocampal neurons a rapid
increase in cAMP is observed inducing neuroprotection, while when DK-PGD2, a DP2
agonist, is added a decrease in cAMP production was observed resulting in neuronal
injury (Liang, Wu, Hand, & Andreasson, 2005). Additionally, it was demonstrated that
the activation of ERK1/2 pathway produced neuroprotection in HC2S2 hippocampal
neurons subjected to oxygen-glucose depravation (E. M. Park et al., 2004). Interestingly,
ERK1/2 was the major pathway for PGD2-DP receptor-mediated protection in
cardiomyocytes (Tokudome et al., 2009).
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The Purpose of these Studies
Based upon the theory of programming diseases, which established that adverse
maternal environment during the gestational period could affect the development of the
fetus and increase the risk to diseases or detrimental health during adulthood, we
hypothesized that maternal hypoxia affects the organogenesis of the kidney and the brain
and program a hypoxic ischemic encephalopathy sensitive phenotype in neonatal rat
brain (figure 1). We began our studies by evaluating how maternal hypoxia affects the
development of kidney in fetal and offspring rats and also determine the effect on the
expression of angiotensin II type I (AT1R) and type 2 (AT2R) receptors (Chapter 2).
Next, we analyzed the effect of maternal hypoxia on the brain vulnerability to hypoxicischemic brain injury in neonatal rats and determine how the expression of glucocorticoid
receptors is affected by this maternal insult. The Vannucci model described previously
was used to mimic a hypoxic-ischemic brain injury model (Chapter 3). Then we studied
a possible mechanism associated with the neuroprotective role of dexamethasone against
hypoxic-ischemic brain (Chapter 4). These studies revealed that 1) maternal hypoxia
affects the organogenesis of the kidney and the brain, 2) maternal hypoxia increases the
brain vulnerability of neonatal rats against HIE brain injury by repressing the expression
of glucocorticoid receptors due to a hypermethylation on the promoter region of GR gene
exon17 and 111, and 3) the mechanism of the neuroprotective role of dexamethasone on
HIE brain injury is associated with the MAPK/ERK pathway, where the LPGDS/PGD
cascade plays an important function.
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Abstract
The present study tested the hypothesis that fetal hypoxia adversely affects kidney
development in fetal and offspring rats and alter the expression patterns of angiotensin II
type 1 and type 2 receptors. Time-dated pregnant rats were divided between normoxic
and hypoxic (10.5% O2 last period of gestation) groups. Protein expression, in the pups,
was determined using western blot. Hypoxic treatment significantly decreased body and
kidney weight in 21-day fetuses and 7-day neonates. In 3-month-old offspring there were
no significant differences in body and kidney weight between hypoxic and control
animals. Fetal hypoxia had no effect on kidney AT1R density in E21 or P7, but
significantly decreased kidney AT1R protein abundance in both male and female adults.
In contrast, kidney AT2R density was not affected by fetal hypoxia throughout the
developmental stages studied. The hypoxia-mediated reduction of nephron numbers was
progressively from P7 worsened into the adulthood with females affected more than
males. The results suggest that fetal hypoxia causes programming of aberrant kidney
development and accelerates the aging process of the kidney during the postnatal
development, which may contribute to an increased risk of cardiovascular disease.
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Introduction
The most critical period of the human being is during fetal development, the stage
in which the mother could expose the fetus to adverse environment that could have a
long-term effect during adulthood. The studies of Barker and colleagues are the
fundament for what is known as developmental programming of diseases in which they
found an inverse relationship between birth weight and cardiovascular diseases later in
the adulthood (Barker, 1995, 1997). Two of the most common challenges to the fetus
during development are reduction in oxygen and nutrient delivery. There are various
maternal stressors that could affect body weight in the offspring, for example maternal
protein-restriction diet (Woods, Ingelfinger, Nyengaard, & Rasch, 2001), nicotine
exposure (Lawrence et al., 2008), intrauterine malnutrition (Zhang et al., 2000), and
hypoxia (Julian et al., 2007).
Retardation of renal development that occurs in individuals of low birth weight
increases the risk of renal diseases during adulthood (Brenner & Chertow, 1994). The
process of nephrogenesis in the rats starts during mid-gestation and finishes after postnatal day 10 (Larsson, Aperia, & Wilton, 1980). Previous studies demonstrated that
maternal low-protein diet in rats resulted in low birth weight, suppressed the renal reninangiotensin system, and reduced the number of nephrons, leading to hypertension in
offspring (Woods & Rasch, 1998). The aging process of the kidney is associated with
physiological and functional changes, including reduced kidney weight and glomerular
number, and changes in the shape of glomeruli and the formation of glomerular arterioles
(Weinstein & Anderson, 2010). These changes in combination with decrease in renal
function lead to hypertension and other cardiovascular diseases. The RAS is associated
with one of the mechanisms that are involved in developmental problems in fetal organs,
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including the kidney (Tufro-McReddie, Romano, Harris, Ferder, & Gomez, 1995).
Angiotensin II is the primary peptide in the system, which activates two subtypes of Gprotein coupled receptors: angiotensin II type 1 and type 2 receptors. The AT1R plays a
key role in the regulation of blood pressure, hormone secretion and renal function while
AT2R is involved mainly in the development and growth (de Gasparo, Catt, Inagami,
Wright, & Unger, 2000).
Little is known about the effect of common fetal stress of hypoxia on the kidney
development. Therefore, in the present study, we determined the effect of fetal hypoxia
on the glomerular development and the expression patterns of AT1R and AT2R in the
kidney in three developmental stages of near-term fetal, neonatal, and adult rats. The
results suggest that fetal hypoxia causes programming of aberrant kidney development
and accelerates the aging process of the kidney during the postnatal development, which
may contribute to an increased risk of cardiovascular disease, particularly hypertension in
offspring.

Material and Methods
Experimental Animals and Hypoxic Exposure
Time-dated pregnant Sprague-Dawley rats were purchased from Charles River
Laboratories (Portage, MI) and were randomly divided into normoxic control group and
continuous hypoxic exposure group. The hypoxic group was exposed to 10.5% oxygen
from day 15 to day 21 of gestation, a period comparable with the third trimester of
gestation in humans. Hypoxia was induced to the pregnant rats by a mixture of nitrogen
gas and air in individual chambers as described previously (G. Li et al., 2003). The
normoxic control group was housed identically with room air flowing through chambers.
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Water and food were provided as desired. Some of the pregnant rats, of both groups, were
allowed to give birth naturally, and no fetal loss in the normoxia or hypoxia groups was
observed. The offspring were allowed to lactation and no further treatment before
euthanasia at postnatal day 7 and 3 month-old. The other pregnant dams were sacrificed
on day 21 of gestation and fetuses were collected for studies. Kidneys were isolated and
stored at -80°C. Body and kidney weight was determined. All procedures and protocols
used in the present study were approved by the Institutional Animal Care and Use
Committee of Loma Linda University and followed the guidelines in the National
Institutes of Health Guide for the Care and Use of Laboratory Animals.

Immunoblotting
Protein abundance of renal AT1R and AT2R was determined with Western blot
analysis as reported previously (Mao et al., 2010). Briefly, kidneys were homogenized in
an ice-cold lysis buffer (20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1
mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride and 2 μg/ml
aprotinin, pH 7.4). Homogenates were centrifuged at 4°C for 10 min at 14,000g, and
supernatants aliquots were collected and stored at -80°C. Protein concentrations were
determined using a protein assay kit from Bio-Rad. Samples with equal protein (40 g)
were loaded on 7.5% sodium dodecyl sulfate polyacrylamide gel and preformed the
electrophoresis analysis. After electrophoresis, proteins were transferred to nitrocellulose
membranes. Nonspecific binding was blocked in TBST containing 5% dry milk for 60
min at room temperature. The membranes were incubated with rabbit AT1R and AT2R
polyclonal antibody (1:1000 and 1:2000 dilution respectively; Santa Cruz Biotechnology,

24

Santa Cruz, CA) overnight at 4°C. The membranes were then washed and incubated with
secondary horseradish peroxidase-conjugated goat anti-rabbit antibody (1:4000 dilution;
Santa Cruz Biotechnology, Santa Cruz, CA). Protein bands were visualized with
enhanced chemiluminescence reagents, and the blots were exposed to Hyperfilm (GE
Healthcare). Results were analyzed and quantified by the Kodak electrophoresis
documentation and analysis system with Kodak ID image analysis software. For
comparison of the levels of AT1R and AT2R protein relative density between the groups,
samples were normalized first to GAPDH values and then presented as fold values
relative to sham-treated animals.

RT-PCR
Three month-old rat kidney RNA was isolated with TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) and subjected to reverse transcription with Superscript III FirstStrand Synthesis System (Invitrogen), following the manufacturer’s instructions. Briefly,
5 µg total RNA was reverse transcribed into cDNA in a 20 µl volume reaction following
the protocol of 50°C for 50 minutes and 85°C for 5 minutes. The mRNA abundance of
AT1aR and AT1bR was measured with real-time PCR using iQ SYBR Green Supermix
(Bio-Rad, Hercules, CA, USA) as described previously and amplification of GAPDH was
used as internal reference. Primers used for AT1aR mRNA: 5′-ccattcaccctgcctcag-3′
(forward) and 5′-acggctttgcttggttactc-3′ (reverse) and for AT1bR mRNA: 5′atgtctccagtcccctctca-3′ (forward) and 5′-tgacctcccatctccttttg-3′ (reverse). Real-time PCR
was performed in a final volume of 25 µl and each PCR reaction mixture consisted of
500 nM of primers and iQ SYBR Green Supermix containing 0.625 unit hot-start Taq
polymerase, 400 µM each of dATP, dCTP, dGTP, and dTTP, 100 mM KCl, 16.6 mM
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ammonium sulfate, 40 mM Tris-HCl, 6 mM MgSO4, SYBR Green I, 20 nM fluorescing
and stabilizers. We used the following real time-PCR protocol: 95°C for 10 minutes,
followed by 40 cycles of 95°C for 10 seconds, annealing for 10 seconds at appropriate
temperature depending on the primer sequence, 72°C for 10 seconds. Serial dilutions of
the positive control were done on each plate to create a standard curve for the
quantification.

Glomerular Counting
The number of glomeruli per kidney was determined for P7 and 3M female and
male rats as previously described (Boubred et al., 2007). Briefly, kidneys were removed
and weighed. Whole kidneys were incubated in 50% hydrochloric acid for 45 min at
37°C, the incubation time being dependent on kidney weight. Kidneys were rinsed with
tap water and stored overnight at 4°C in a gauged flask. Following mechanical
dissociation, tubules and glomeruli were suspended in 10 ml of distilled water. Three 0.5ml aliquots were obtained from each kidney homogenate and placed in a hemocytometerlike chamber, and glomeruli were counted under microscope by two investigators who
were unaware of the specimen origin. The three results were averaged, and then the value
was used to determine the total number of glomeruli in the sample and therefore in the
kidney.

Statistical Analysis
Results are expressed as mean ± standard error of mean. Experimental number
(n) represents fetuses and offspring from different dams. Statistical comparisons for the
body and kidney weight, the kidney to body weight ratio, and the number of glomeruli
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were conducted by two-way ANOVA followed by a Bonferroni test. Differences in AT1R
or AT2R protein abundance between normoxic and hypoxic groups were compared using
unpaired t-test analysis. In all cases the differences were considered significant when P <
0.05.

Results
Effect of Fetal Hypoxia on Body and Kidney Weight
Fetal hypoxia resulted in a significant decrease in body and kidney weight in E21
and P7 rats (Figure 1A, 1B). The kidney-to-body weight ratio was significantly higher in
P7 rats than that in E21 rats (Figure 1C), indicating a continuous growth and maturation
of the kidney in neonatal rats. Hypoxia treatment decreased the kidney-to-body weight
ratio in E21 rats but increased it in P7 rats (Figure 1C). In 3M offspring, there were no
significant differences in body and kidney weight in either males or females between the
control and hypoxic-treated animals (Figures 1D and 1E). The kidney-to-body weight
ratio was not significantly different between males and females in adult offspring, but
both were significantly decreased as compared with that in P7 neonates (Figures 1C and
1F). Fetal hypoxia had no significant effect on the kidney-to-body weight ratio in either
male or female adult offspring (Figure 1F).
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Effect of Fetal Hypoxia on Renal AT1R and AT2R Protein and mRNA
Abundance
The protein abundance of AT1R and AT2R in the kidney was determined by
Western blot analysis. As shown in figure 2, AT1R protein abundance in the kidney was
not significantly different in either fetal or neonatal rats between the control and hypoxictreated animals. However, in adult offspring, AT1R protein abundance in the kidney was
significantly decreased in both males (43%) and females (62%) that had exposed to
hypoxia before birth, as compared with the control animals (Figure 2). In contrast, fetal
hypoxia had no significant effect on AT2R protein abundance in the kidney at all three
developmental stages examined (Figure 4) Consistent with the finding of protein
abundance for 3M offspring, fetal hypoxia exposure caused a significant decrease in
AT1R mRNA abundance in the kidney of both male and female (Figure 3). Similar
results were obtained on the ratio between kidney AT1R and AT2R where the fetal
hypoxia decrease this ratio for male and female adult offspring (Figure 5).
.
Effects of Fetal Hypoxia on Glomerular Number
Figure 4 shows the effect of fetal hypoxia on total number of glomeruli per kidney
in neonates and adult offspring. In P7 neonates, there was a small but significant
decrease in kidney glomerular numbers in hypoxic-treated animals, as compared with the
normoxic pups (Figure 6). This hypoxia-mediated reduction of nephron numbers was
progressively worsened into the adulthood with females (52% reduction) affected more
than males (26% reduction) (Figure 6).
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Discussion
There is plenty of evidence that correlates low birth weight in term gestation with
an increased risk of cardiovascular disease during adulthood (Eriksson et al., 1999). The
present finding that fetal hypoxia caused a significant decrease in the body weight of fetal
and neonatal rats is consistent with the previous studies (Tapanainen et al., 1994). No
significant difference was observed in the adult offspring between normoxia and
hypoxia-treated animals in the present study, suggesting “catch-up” growth during
postnatal development in hypoxia-treated animals. A number of studies have shown that
in utero undernutrition causes fetal growth restriction and low birth weight, which is
associated with “catch-up” growth during postnatal development (Chen, Martin-Gronert,
Tarry-Adkins, & Ozanne, 2009; Woods, Weeks, & Rasch, 2004). These studies suggest a
common response of decreased body weight in early developmental stage and “catch-up”
growth in postnatal development in fetal malnutrition and fetal hypoxia models. It has
been shown that low birth weight associated with accelerated postnatal growth is a trigger
for development of adult disease and ultimately can affect longevity (Woods, Ingelfinger,
& Rasch, 2005).
In the present study, fetal hypoxia resulted in a decrease in the kidney weight in
the fetus and neonate. However in adult offspring, the kidney weight was not
significantly different between the control and hypoxic-treated animals in both females
and males. Interesting, perinatal nicotine exposure affected the kidney weight not just in
the fetus and neonate but also in female and male adult offspring (Mao et al., 2009). The
finding that the kidney-to-body weight ratio was significantly greater in P7 rats than that
in E21 rats indicates a continuous growth and maturation of the kidney in neonatal rats.
This is consistent with the previous finding that the process of nephrogenesis in the rats
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starts during mid-gestation and finishes after post-natal day 10 (Larsson et al., 1980).
The finding that the kidney-to-body weight ratio was significantly decreased in adult rats
as compared with that in neonatal rats is intriguing and suggests asymmetric growth and
aging process of reduced kidney weight during the postnatal development 11. Hypoxia
decreased the kidney-to-body weight ratio in E21 rats. It has been demonstrated that fetal
hypoxia results in a decrease in amniotic fluid production and redistribution of fetal blood
flow with a decrease in perfusion to the kidney and an increase of perfusion to the brain,
heart and liver (Luzi et al., 1996). The finding of the increased kidney-to-body weight
ratio in P7 rats in hypoxic animals suggests a compensatory growth of the kidney in
neonates. Similar to the present finding, maternal protein restriction caused a decrease in
the kidney-to-body weight ratio in the newborn and P1 offspring, but in P5 there was no
difference in the ratio between the low protein diet and control groups (Woods et al.,
2004).
Abnormal development of the kidney may affect adult cardiovascular and renal
function. Brenner et al. (Brenner, Garcia, & Anderson, 1988) introduced the hypothesis
that due to a lower nephron number the surface area of filtration is smaller, leading to an
increase in glomerular pressure and systematic hypertension. We demonstrated in the
present study that fetal hypoxia decreased the nephron number in the offspring as early as
P7 neonatal rats. In figure 6 the diference observed in the number of glomeruli between
normoxia and hypoxia groups for P7 is less than that observed in adults. It is generally
perceived, at least in human, that the number of glomeruli does not change after birth but
as mentioned aboved the nephrogenesis proces for rats started during mid-gestation and
finishes after P10 whereby the maturation process still has not completed and therefore
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the number of nephrons for normoxia group (P7) is smaller than the observed on adults.
Altough the nephron number would not change during adulhood however the total
glomerular volume may increase during adulthood due to fully-perfused glomeruli. As
the kidney matures, more glomeruli will become funcional as reflected by an increase in
GFR. In figure 1, there is no difference in the kidney-to-body weigth ratio for adults rat,
eventhough the number of glomeruli is lower for the hypoxia group as demostrated in
figure 6. This observation could be due to glomerular hypertrophy that maintain the renal
filtration surface area, which may in turn lead to adverse effects in the kidney as a result
of chronic glomerular hyperfiltration (Hostetter, 2003).
There is plenty of evidence regarding the existence of a relationship between
lower nephron number and hypertension in humans (Keller, Zimmer, Mall, Ritz, &
Amann, 2003) and in rats (Gray, Denton, Cullen-McEwen, Bertram, & Moritz, 2010).
Several different animal models including maternal alcohol administration and high salt
diet during pregnancy demonstrated the reduced nephron number and increased blood
pressure in adult offspring (Gray et al., 2010). Woods et al. reported that the maternal
protein restriction decreased the number of nephrons in adult kidneys. Interesting, they
found that although the degree of hypertension in male and female adult rats was similar,
the number of nephrons in males was lower than that in females (Woods et al., 2004). In
contrast to the findings in animal models of low protein diet and high salt diet (Woods et
al., 2004), fetal hypoxia resulted in a greater reduction in the nephron number in female
(52%) than male (26%) adult offspring. These findings suggest differential effects of fetal
insults on gender-specific programming of aberrant nephron development. The finding
that hypoxia-mediated reduction of nephron numbers was progressively worsened into
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the adulthood is intriguing and suggests that fetal hypoxia causes programming of
aberrant kidney development and accelerates the aging process of the kidney during the
postnatal development, which may contribute to an increased risk of cardiovascular
disease, particularly hypertension in offspring. It has been shown that the aging process
of the kidney is associated with reduced glomerular number, which contributes to an
increased risk of hypertension and other cardiovascular diseases.
The Renin-Angiotensin System is a key regulator of blood pressure,
fluid/electrolyte homeostasis, and kidney development (Kobori et al., 2006; Woods et al.,
2001). A recent study demonstrated that prenatal nicotine exposure did not affect the
expression of AT1R in rat kidneys of 14-days, 30-days and 3-month offspring, as
compared with the control groups 21. However, the nicotine treatment decreased the
expression of AT2R in all the three post-natal ages. Here we reported that fetal hypoxia
decreased the mRNA and protein expression of AT1R just in adult offspring (5M) and the
expression of AT2R was not affected by this maternal stress suggesting that different
maternal stress could affect the organogenesis of the kidney in different manners.
Additionally, it has been shown that maternal protein restriction diet suppresses the
expression of renal RAS probably due to the reduced number of glomeruli per kidney,
which is associated with the increased arterial blood pressure in the adult rats (Woods et
al., 2001).
It has been reported that AT1R and AT2R have a regulatory role in renal
homodynamic and in tubular function, which is antagonist one form the other. Due to
this, the balance between these two receptors can determine the renal status in health and
disease. Although the expression of AT1R and AT2R alone is not a measure of kidney
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function, a significant reduction of AT1R/AT2R protein density ratio in the kidney of
adult offspring, whose mother were exposed to hypoxia during pregnancy, indicates that
the renal function could be affected. Also these receptors coupled with ANG Iconverting enzyme, which forms ANG II in the circulation are associated with the
maintenance of blood pressure through renal and vascular mechanisms. Li et al (X. C. Li
& Zhuo, 2008) demonstrated the intracellular expression of ANG II induces a significant
increase in blood pleasure that was associated with a higher expression of sodium
hydrogen exchange transporter that is coupled with ANG II-AT1 receptor axis. Using
losartan, an antagonist for AT1R, Woods et al. demonstrated that AT1R played a key role
in fetal programming of aberrant renal development and hypertension in offspring
(Woods & Rasch, 1998). In the present study, we demonstrated that fetal hypoxia did not
affect the expression of AT1R in E21 and P7 rats, but significantly decreased AT1R
expression in adult offspring. Additionally, this effect is more pronounced in females
than males. This is consistent with the finding of the greater reduction in nephron
numbers in female than male adult offspring and suggests that the decreased AT1R in
adult kidneys is due to reduced nephron numbers in hypoxic-treated animals. This finding
raise the possibility of a sex-dependent effect due to maternal hypoxia on the renal AT1R
expression might lead to sex differences on the impact of maternal hypoxia on adult
disease. This could be evaluated in future studies. The finding that AT2R in the kidney
was not significantly affected by fetal hypoxia in all the developmental ages examined in
the present study suggests a predominate location of AT2R in extra-nephron tissues in the
kidney. Indeed, Miyata et al. (Miyata, Park, Li, & Cowley, 1999) demonstrated that
AT1R, but not AT2R, mRNA was detected in the nephron.
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Although AT1R plays an important role in normal kidney development (Oliverio
et al., 1998), fetal hypoxia had no effect on AT1R in the kidney but decreased nephron
numbers in P7 rats, suggesting other mechanisms may be involved in the hypoxiamediated abnormal nephron development. Possible mechanisms associated with the
reduction of glomeruli that could be explore are the potential effects of fetal hypoxia on
Wnt4 that is required by the metanephric mesenchyme for differentiation into nephron
epithelia (Stark, Vainio, Vassileva, & McMahon, 1994), or fibroblast growth factor-2
(Karavanova, Dove, Resau, & Perantoni, 1996) and transforming growth factor -2
(Sanford et al., 1997) that are capable of inducing nephrons remain an intriguing area for
future investigation. Another possible mechanism to explore is to evaluate how prenatal
hypoxia affects the expression of retinoid receptors, which mediates remodeling process
in epithelial cells associated with nephron genesis (Batourina et al., 2001). Additionally,
it has been shown that hypoxia increases the expression of glucocorticoid receptors in the
primary human renal cortex epithelial cells (Jenq, Rabb, Wahe, & Ramirez, 1996), and
that glucocorticoids play an important role in accelerating the maturation process of the
kidney function (Petershack, Nagaraja, & Guillery, 1999; Seckl, 2004). Furthermore, the
previous study demonstrated that hypoxia up-regulated the expression of angiopoietin-2
in cultured mouse kidney mesangial cells, which may have a synergistic paracrine role in
the growth of glomerular endothelial during the development of the kidney (Yuan, Yang,
& Woolf, 2000). In humans, it has been shown that the aging process of the kidney
induces changes in anatomic and function of the renal system, including reduction of
glomerular filtration rate, segmental glomerular sclerosis, reduction in the number of
glomeruli and a decrease in renal mass (Epstein, 1996). These changes may result in
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chronic kidney diseases a risk factor that eventually induced cardiac complications. Our
results suggest that fetal hypoxia induces aberrant nephrogenesis and accelerates the
aging process of the kidney. Additionally, the results suggest that the mechanisms other
than the renal RAS may be involved in fetal hypoxia-mediated programming of abnormal
kidney development. Future studies are required to further elucidate these unknown
pathways.
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CHAPTER THREE
FETAL HYPOXIA INCREASES VULNERABILITY OF HYPOXICISCHEMIC BRAIN INJURY IN NEONATAL RATS: ROLE OF
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Abstract
Gestational hypoxia is a common stress to the fetal development and increases the
risk of neonatal morbidity. We tested the hypothesis that fetal hypoxia results in
heightened brain vulnerability to hypoxic-ischemic injury in neonatal rats via downregulation of glucocorticoid receptor in the developing brain. Time-dated pregnant rats
were exposed to hypoxia (10.5% O2) from day 15 to 21 of gestation. Brain HI injury was
determined in day 10 pups. Maternal hypoxia resulted in asymmetric intrauterine growth
restriction in the fetus. The brain HI injury was significantly increased in maternal
hypoxia-treated pups as compared with the normoxia control in both males and females.
Activation of brain GR by intracerebroventricular administration of dexamethasone
produced a concentration-dependent reduction of HI-induced brain injury in control pups.
Maternal hypoxia significantly decreased GR mRNA and protein abundance in the fetal
brain and neonatal hippocampus and abolished the dexamethasone-mediated
neuroprotective effect in pup brains. This was resulted from increased DNA methylation,
decreased binding of transcription factors Egr-1 and Sp1 to GR gene exon 17 and 111
promoters, and reduced expression of GR exon 17 and 111 mRNA variants. The results
demonstrate that gestational hypoxia causes epigenetic repression of GR gene expression
in the developing brain resulting in the heightened brain vulnerability to HI injury in
neonatal rats.
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Introduction
Hypoxic-ischemic encephalopathy is the most common cause of brain damage
due to systemic asphyxia, which may occur prior, during or after birth (Douglas-Escobar
and Weiss, 2012). HIE occurs in about 2% of full-term infants and close to 60% in
premature newborns, and causes significant mortality and lead to long-term neurologic
sequelae, including learning disabilities, mental retardation, seizure and cerebral palsy
(Graham et al., 2008; Kurinczuk et al., 2010). Although little is known about the
pathogenesis of HIE, recent studies have suggested that adverse intrauterine environment
may contribute to aberrant brain development (Tomalski and Johnson, 2010; Li et al.,
2012). Hypoxia is a common form of intrauterine stress, and the fetus may experience
prolonged hypoxic stress under a variety of conditions, including pregnancy at high
altitude, pregnancy with anemia, placental insufficiency, cord compression, preeclampsia,
heart, lung and kidney disease, or with hemoglobinopathy. Although it has been shown
that fetal hypoxia affects normal brain development and induces neurological deficit in a
variety of behavioral tests in offspring (Li et al., 2012), the effect of fetal hypoxiamediated stress on newborn brain HIE remains elusive.
Many factors may be involved in the stress response in the developing brain.
Among them, glucocorticoids are essential for the brain development and play a center
role in the response to stress. The effects of glucocorticoids are mainly mediated via
binding to glucocorticoid receptors, and GRs are highly expressed in the developing brain
with dynamic and complicated ontogeny. It has been demonstrated in humans and
rodents that early life environment and events are critical in programming tissue-specific
GR expression levels, particularly in the hippocampus (Xiong and Zhang; Weaver et al.,
2005; Weaver et al., 2007; Mueller and Bale, 2008; Oberlander et al., 2008; Turner et al.,
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2008; Turner et al., 2010; Li et al., 2012). Both neurodegenerative and neuroprotective
effects of glucocorticoids have been reported (Abraham et al., 2001). Glucocorticoids
have been shown to affect the vulnerability of fetal and neonatal brains to hypoxiaischemia challenge; however, the results were inconsistent and dependent on
experimental protocol, dosage, timing, animal age, strains and species (Tombaugh et al.,
1992; Kauffman et al., 1994; Tuor, 1995; Flavin, 1996; Tuor, 1997; Whitelaw and
Thoresen, 2000). It appears that the concentration and duration of glucocorticoid
treatment are the two key factors determining either detrimental or beneficial effects of
glucocorticoids in the brain. Although exposure to long-term and high levels of
glucocorticoids enhances neurotoxic effects in brain injury, physiological or slightly
supra-physiological levels of glucocorticoids confer the brain protective effect to HIE
challenges (Abraham et al., 2001). Herein, we present evidence of a novel finding that
chronic fetal hypoxia down-regulates GR expression in the developing brain resulting in
the increased brain susceptibility to HI injury in neonatal rats, and suggest new insights
of molecular mechanisms linking fetal hypoxia to the heightened HIE vulnerability in
newborns.

Materials and Methods
Experimental Animals
Pregnant Sprague Dawley rats were randomly divided into 2 groups: normoxic
control and hypoxic treatment of 10.5% O2 from day 15 to 21 of gestation, as described
previously (Patterson et al., 2010). Given that hypoxia decreased maternal food intake by
approximately 40%, a group of pregnant rats were randomized to 60% of control food
intake under the normoxic condition during the same gestational period as a pair-fed
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control. On day 21 of pregnancy, some rats were euthanized and fetal brains were
isolated. Other rats were allowed to give birth, and further studies were conducted in 10day-old neonatal pups of both sexes. All procedures and protocols were approved by the
Institutional Animal Care and Use Committee of Loma Linda University and followed
the guidelines by the National Institutes of Health Guide for the Care and Use of
Laboratory Animals.

Brain HI Treatment
Brain HI injury was induced in P10 pups, as previously described (Li et al., 2012).
Pups were anesthetized with 2% isoflurane and the right common carotid artery was
ligated. After recovery for 1 hour, pups were treated with 8% O2 for 1.5 hours. To
determine the role of GR in brain HI injury, GR agonist dexamethasone (Sigma-Aldrich)
was injected into the right lateral ventricle prior to the HI treatment. Pups were
anesthetized and fixed on a stereotaxic apparatus (Stoelting, Wood Dale, IL). An incision
was made on the skull surface and bregma was exposed. Dexamethasone was injected at
a rate of 1 l/minute with a 10 l syringe (Stoelting, Wood Dale, IL) on the right
hemisphere following the coordinates relative to bregma: 2 mm posterior, 1.5 mm lateral
and 3.0 mm below the skull surface (Li et al., 2012). Saline was injected as the vehicle
control. The injection lasted 2 minutes and the needle was kept for additional 5 minutes
before its removal. The incision was sutured.

Measurement of Brain Infarct Size
Forty-eight hours after the HI treatment, pups were sacrificed and brain infarct
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size was determined as previously described (Li et al., 2012). Briefly, coronal slices of
the brain (2 mm thick) were cut and immersed in a 2% solution of 2,3,5triphenyltetrazolium chloride monohydrate (Sigma-Aldrich) for 5 minutes at 37°C and
then fixed by 10% formaldehyde overnight. Each slice was weighed, photographed
separately and the percentage of infarction area for each slice was analyzed by Image J
software (Version 1.40; National Institute of Health, Bethesda, MD), corrected by slice
weight, summed for each brain, and expressed as a percentage of whole brain weight.

Western Blot
GR protein abundance was determined by Western blot (Xue et al., 2011).
Briefly, brains were homogenized and protein concentrations in supernatants were
determined. Samples with equal amounts of proteins were separated by electrophoresis,
and were probed with primary antibodies against GR or HIF 1 (Santa Cruz
Biotechnology). Membranes were then incubated with a horseradish peroxidaseconjugated secondary antibody, and proteins were visualized with enhanced
chemiluminescence reagents. The target protein abundance was normalized to actin.

Real-time RT-PCR
Total RNA was isolated and subjected to reverse transcription with Superscript III
First-Strand Synthesis System (Invitrogen). The abundance of GR mRNA and the
alternate exon 1 variants was measured with real-time PCR using iQ SYBR Green
Supermix (Bio-Rad), as described previously (Meyer et al., 2009; Xiong et al., 2012).
Primers used were listed in Table 1. Real-time PCR was performed in a final volume of
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25 µl and each PCR reaction mixture consisted of 500 nM of primers and iQ SYBR
Green Supermix containing 0.625 unit hot-start Taq polymerase, 400 µM each of dATP,
dCTP, dGTP, and dTTP, 100 mM KCl, 16.6 mM ammonium sulfate, 40 mM Tris-HCl, 6
mM MgSO4, SYBR Green I, 20 nM fluorescing and stabilizers. We used the following
real time-PCR protocol: 95°C for 5 minutes, followed by 40 cycles of 95°C for 10
seconds, annealing for 10 seconds at appropriate temperature depending on the primer
sequence, 72°C for 10 seconds. Serial dilutions of the positive control were done on each
plate to create a standard curve for the quantification. PCR was done in triplicate and
threshold cycle numbers were averaged for each sample.

Methylated DNA Immunopreciptation
MeDIP assays were performed with the MeDIP kit (Active Motif, Carlsbad, CA,
USA), following the manufacturer’s instruction. Briefly, genomic DNA was extracted
from tissues and sonicated to yield fragments ranging in size from 200 to 600 base pairs.
The double strand DNA fragments were denatured at 95 C to produce single strand
DNA, and a 5-methylcytosine (5-mC) antibody was then used to precipitate DNA
containing 5-mC. The 5-mC enriched DNA was subjected to PCR analysis with primers
flanking the GR promoter and the PCR products were visualized with 3% agarose gel
stained with ethidium bromide and analyzed with ImageJ software. Two sets of primers
flanking transcription factor binding sites SP1 and Egr-1 at exon 17 promoter and SP1 at
exon 111 promoter were used: 5′-agcccctctgctagtgtgac-3′ (Promoter-17-F), 5′tttctcttctcccaggctcc-3′ (Promoter-17-R); 5′-agtctggcgtcctttttggt-3′ (Promoter-111-F), 5′ccaatccaccctacaagccc-3′ (Promoter-111-R).
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Table 1. Primer sequences for GR and GR gene first exons.

Forward

exon 14

AAGCAACACCGTAACACCTT

exon 15

CATGCAACTTCCTCCGAGT

Reverse

AGAAGCAGCAGCCACTGA
exon 17

GGAGCCTGGGAGAAGAGAAA

exon 111

GCCGCAGAGAACTCAACAG

exon 110

CACGCCGACTTGTTTATC

TCTGCTGCTTGGAATCTG

exon 16

ACCTGG CGG CAC GCG AGT

GCAGCCACTGAGGGCGAAGA

exon 18

GACAGTCGCCAACAGGTTAA

TGAGAAGCAGCAGCCACT

exon 19

GTCAGTGCCTGGAGCCCGAG

AGCAGCCACTGAGGGCGAAG

GR

AGGTCTGAAGAGCCAAGAGTTA

TGGAAGCAGTAGGTAAGGAGAT

actin

TCAGGTCATCACTATCGGCAAT

ACTGTGTTGGCATAGAGGTCTT
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Chromatin Immunoprecipitation
ChIP assay was performed using the Chip-IT Express Kit (Active Motif), as
described previously. Briefly, tissues were minced and fixed with 1% formaldehyde to
crosslink and maintain the DNA/protein interactions. After the reactions were stopped
with glycine, tissues were washed with PBS. Chromatin extracts were sonicated to
produce DNA fragments between 200 and 600 base pairs. Antibody against Sp1, MeCP2
(Active Motif), Egr-1 (Santa Cruz Biotechnology), and MBD1 (Abcam) were incubated
with the chromatin extracts to precipitate the transcription factor/DNA complexes.
Crosslinking was then reversed using a salt solution and proteins were digested with
proteinase K. The antibody-pulled chromatin extracts were subjected to PCR assay using
two sets of primers that flank the predicted transcription factor binding sites at GR exon
17 and exon 111 promoters, as described above in MeDIP. PCR products were visualized
by 3% agarose Gel stained with ethidium bromide and analyzed with ImageJ software.

Statistical Analysis
Data are expressed as mean ± SEM. Experimental number (n) represents fetuses
and neonates from different dams. Statistical significance (P < 0.05) was determined by
analysis of variance followed by Neuman-Keuls post hoc testing or Student's t test, where
appropriate.

Results
Maternal Hypoxia Induced Asymmetrical Growth Restriction in the
Fetus
There was no significant difference in the litter size between normoxia control
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(10.0 ± 1.6) and hypoxic (10.7 ± 0.8) groups. Maternal hypoxia resulted in a significant
decrease in body and brain weight in E21 fetuses, but a significant increase in the brain to
body weight ratio (Figure 1). In P10 pups, no significant differences in body and brain
weight were observed between control and hypoxic animals, suggesting a catch-up
growth of hypoxic neonates.

Maternal Hypoxia Increased Neonatal Brain Vulnerability to HI Injury
Maternal hypoxia significantly increased protein abundance of HIF-1α in both,
the fetal and P10 pup brain (Figure 2), indicating hypoxia in the fetal and P10 pup brain.
To evaluate the effect of fetal hypoxia on brain lesion vulnerability, pups from normoxic
and hypoxic animals were induced to brain lesion by HI at P10. Prenatal hypoxia
significantly increased HI-induced brain infarct size in both male and female pups
(Figure 3). To verify that this effect was not due to decreased maternal food intake by
hypoxia, a pair-fed study of approximately 60% maternal food intake as that observed in
hypoxic pregnant rats was conducted. No significant differences were observed in HIinduced brain infarct size in P10 pups by maternal food restriction (Figure 4).

Dexamethasone Reduced HI-Induced Neonatal Brain Damage
The neuroprotective effect of dexamethasone on HI-induced neonatal brain
damage was examined via intracerebroventricular administration of dexamethasone prior
to the HI treatment. Figure 5 shows a concentration-dependent neuroprotective effect of
dexamethasone on HI-induced brain injury in both male and female pups.
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Maternal Hypoxia Down-Regulated GR Expression in the Developing
Brain
The effect of maternal hypoxia on GR protein and mRNA abundance in the
developing brain was shown in figure 6. Maternal hypoxia resulted in a significant
decrease in protein and mRNA abundance of GR in brains of both female and male E21
fetuses (Figure 6A). In P10 neonates, maternal hypoxia significantly reduced GR
expression in the hippocampus (Figure 6B).

Maternal Hypoxia Selectively Decreased GR Alternative Exon 1
mRNA Variants
GR gene has multiple alternative first exons that play important roles in regulating
tissue specific expression of GR, and each exon 1 has its own promoter (Xiong and
Zhang). Among the multiple exon 1s, exon 14 to 111 are located in the proximal region
ranged from about -4.2 to -1.7 Kb upstream of exon 2, and exhibit substantial promoter
activities. All exon 1 variants have unique splice donor sites and share a common exon 2
splice acceptor site, encoding a common protein. To investigate the effect of fetal
hypoxia on the levels of specific GR exon 1 transcripts, quantitative RT-PCR assays were
carried out with primers designed to amplify specific mRNA transcripts containing GR
exon 14 to exon 111. As shown in figure 7A, in brains of both male and female fetuses,
the abundance of exon 17 and 111 containing transcripts was significantly decreased by
the hypoxic treatment. Other GR exon 1 mRNA variants were not changed by hypoxia.
Similar reductions of exon 17 and 111 transcripts were also demonstrated in the
hippocampus of P10 neonates (Figure 7B).
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Maternal Hypoxia Increased Methylation of GR 17 and 111 Promoters
Accumulating evidence indicates that prenatal stress may affect GR gene
expression through epigenetic modification of promoter methylation (Mulligan et al.,
2012). The effects of maternal hypoxia on DNA methylation of GR exon 17 and 111
promoters were determined by precipitation of methylated DNA and subsequent PCR
analysis. Promoter methylation of GR exons 17 and 111 in the fetal brain was significantly
increased by maternal hypoxia (Figure 8).

Maternal Hypoxia Reduced Transcription Factor Binding to GR Exon
17 and 111 Promoters
To determine the functional significance of increased promoter methylation, the
binding of methyl-CpG binding proteins MeCP2 and MBD1, as well as transcription
factors Sp1 and Egr-1 to GR exon 17 and 111 promoters was determined in the fetal brain
by ChIP assays. As shown in figure 9, maternal hypoxia significantly increased the
binding of MeCP2 to both GR exon 17 and 111 promoters, but had no effect on the
binding of MBD1 to the GR promoters. On the other hand, maternal hypoxia
significantly decreased the binding of Egr-1 to exon 17 promoter and Sp1 to exon 111
promoter, respectively, in the fetal brain (Figure 9).
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Maternal Hypoxia Abrogated the Neuroprotective Effect of Dexamethasone
The functional significance of fetal hypoxia-induced down-regulation of GR in
the developing brain was determined by evaluating dexamethasone-mediated
neuroprotective effect of HI-induced neonatal brain injury in the hypoxia-treated animals.
As shown in figure 10, maternal hypoxia abolished dexamethasone-induced
neuroprotective effect of HI-induced neonatal brain injury in both male and female pups.

Discussion
The present study demonstrates for the first time that fetal hypoxia increases the
vulnerability of neonatal brains to hypoxic-ischemic encephalopathy in a rat model.
Intracerebroventricular administration of a synthetic glucocorticoid dexamethasone
protects the neonatal brain from hypoxic-ischemic brain injury, suggesting a local and
direct neuroprotective effect of GR activation in the neonatal brain. Fetal hypoxia
significantly down-regulates GR expression in the developing brain and abrogates the
GR-mediated neuroprotection in the neonatal brain.
The finding that fetal hypoxia and asymmetrical growth restriction increased the
vulnerability of neonatal rat brains to HI-induced injury suggests a novel mechanism in
the understanding of pathogenesis of HIE that occurs at a significantly higher rate in
compromised pregnancy and fetal development. The stage of brain development in P10
neonatal rats is approximately equivalent to that in full-term human baby (Rice et al.,
1981; Towfighi et al., 1991). The approach of the Vannucci model in inducing HI injury
in P10 rat brains provided a means of evaluating potential brain injury caused by birth
asphyxia in full-term newborns. This model consists of unilateral common carotid artery
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ligation followed by systemic hypoxia produced by the inhalation of 8% oxygen
(Vannucci and Vannucci, 2005). Although there is a large body of evidence indicating a
close link between fetal stress and an increased risk of cardiovascular and metabolic
syndrome, stroke, and neurobehavioral pathogenesis in adolescence and/or adulthood,
little is known about the effect of fetal stress on the susceptibility of neonatal HIE.
Consistent with the present finding, a recent study demonstrated that maternal nicotine
administration resulted in the increased vulnerability of HI-induced brain injury in
neonatal rats (Li et al., 2012). Thus, these findings provide new insights linking fetal
stress and pathophysiological consequences of heightened HIE in newborns. The lack of
effect of maternal food restriction in the pair-fed study suggests a hypoxia-specific effect
on the vulnerability of HI-induced brain injury in neonatal rats.
Although the mechanisms underlying fetal stress-induced increase in neonate
brain HI injury remain largely elusive, the present study demonstrated that
intracerebroventricular administration of dexamethasone produced a concentrationdependent decrease of HI-induced brain injury in both male and female neonatal rats,
suggesting a neuroprotective effect of local and direct activation of GR in neonatal
brains. Dexamethasone is a synthetic glucocorticoid that provides protection against
hypoxic ischemic brain damage (Tuor et al., 1997). The present finding is consistent
with the previous studies showing a dose-dependent inhibition of hypoxic-ischemic brain
injury in neonatal rats by dexamethasone (Barks et al., 1991; Feng et al., 2011). More
importantly, the present study demonstrated that fetal hypoxia abrogated the
dexamethasone-induced neuroprotective effect in the neonatal brain, suggesting a
possible mechanism of GR in fetal stress-mediated vulnerability of HIE in the neonate.
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The loss of dexamethasone-mediated neuroprotection in the neonate in hypoxic
animals is likely due to the down-regulation of GR expression in the developing brain.
The GR activity in regulating tissue and cell function relies on a tight control of its
expression levels. In both humans and rodents the regulation of GR levels occurs almost
exclusively at the transcriptional level. Early-life environmental events play a key role in
programming of tissue GR levels (O'Donnell et al., 1994; Liu et al., 1997; Bertram et al.,
2001; Weaver et al., 2004). In the present study, GR protein and mRNA abundance in
fetal and neonatal brains was significantly decreased by fetal hypoxia. This is consistent
with the previous finding that fetal hypoxia resulted in a significant decrease in GR
expression in fetal and neonatal hearts (Xue et al., 2011). These findings suggest that the
down-regulation of GR may be a common response to fetal stress among tissues. Human
and rat GR genes show a high similarity and both have 11 untranslated exon 1s, all of
which have unique splice donor sites and share a common exon 2 splice acceptor site,
encoding a common protein (McCormick et al., 2000; Turner and Muller, 2005; Turner et
al., 2006). Similar to human GR gene, in rats, 8 of the alternate exon 1s, 14 to 111, are
located in the proximal region upstream of exon 2, and exhibit substantial promoter
activities (McCormick et al., 2000). Whereas the mechanisms regulating the differential
usage of these first exons in different tissues and individuals, and the role of the 5’
untranslated region in splicing of the coding exons remain poorly understood, multiple
first exons plus modulation of alternative first exon activity by their promoters represent
the complexity orchestrated by tissue-specific transcription factors in programming of
GR expression patterns in a tissue-specific manner. In the present study, we found that
fetal hypoxia resulted in a significant decrease in expression levels of GR mRNA variants
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containing exon 17 and 111 in fetal brains, which sustained in the hippocampus of P10
neonatal brains. Whereas exon 17 has been shown to play an important role in regulating
hippocampus GR expression and in “resetting” the HPA axis sensitivity resulting from
maternal care and neonatal handling (McCormick et al., 2000; Oberlander et al., 2008),
fetal stress-mediated modulation of exon 111 expression in regulating GR expression in
the brain has not been reported. Indeed, a previous study suggested that neonatal
handling had no significant effect on the expression of exon 111 in rat hippocampus
(McCormick et al., 2000). Thus, the present finding of fetal hypoxia-induced downregulation of exon 111 demonstrates the complexity of GR exon 1s involved in stressspecific and developmental age-specific regulation of GR expression in the developing
brain, and suggests a novel mechanism of exon 111 in regulating brain GR expression
patterns caused by fetal hypoxia.
The finding that fetal hypoxia-induced brain GR down-regulation sustained in the
P10 neonate suggests a permanent GR repression in the developing brain. Accumulating
evidence indicates that perinatal stress affects GR gene expression mainly through
epigenetic mechanisms, and increased methylation of GR promoters has been associated
with early life experiences in both humans and rats (Oberlander et al., 2008; Suderman et
al., 2012). As important regulators of chromosome structure and gene expression, the
methyl-CpG binding proteins, MeCP2 and MBD1 can bind to 5’ methylated cytosine of
CpGs on DNA and suppress gene expression (Guy et al., 2011). The present study
showed the binding of both MeCP2 and MBD1 to the promoters of GR exon 17 and 111 in
the fetal brain, and the binding of MeCP2 was significantly increased by fetal hypoxia.
Increased methyl-CpG binding proteins to GR promoters is likely to induce chromatin
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remodeling that make local chromatin structure more condensed and less accessible to
transcription factor binding (Jones et al., 1998; Nan et al., 1998; Jaenisch and Bird,
2003). Indeed, the present study demonstrated a significant decrease in the binding of
Egr-1 to GR promoter 17 and Sp1 to GR promoter 111, respectively, providing a novel
mechanism in fetal stress-induced down-regulation of GR expression in the brain at the
molecular level. Among the transcription factor binding sites defined on GR promoters,
the NGFI-A (Egr-1) binding site at rat promoter 17 and equivalent human promoter 1F
has been extensively studied in perinatal programming of GR expression and subsequent
disease (Weaver et al., 2004). Sp1 binding sites have also been reported to regulate GR
gene expression (Suehiro et al., 2004). In agreement with the present study, previous
studies demonstrated that fetal stress resulted in heightened CpG methylation and
decreased Egr-1 and Sp1 binding to PKC epsilon promoter, leading to down-regulation of
PKC epsilon expression in the developing heart (Patterson et al., 2010; Lawrence et al.,
2011). It is thus plausible that transcription factors including Egr-1 and Sp1 and their
corresponding binding sites on specific gene promoters are common targets of epigenetic
regulation by perinatal environments.
The present investigation provides novel evidence that fetal hypoxia increases HIinduced brain injury in neonatal rats, providing new insights linking fetal stress and
pathophysiological consequences of heightened HIE in newborns. Although it may be
difficult to translate the present findings directly into humans, the possibility that fetal
hypoxia may increase the risk of HIE in newborns provides a mechanistic understanding
worthy of investigation in humans. This is because hypoxia is one of the most important
and clinically relevant stresses to the fetus and because HIE occurs at a significantly
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higher rate in compromised pregnancy and fetal development. The finding of fetal stressmediated epigenetic repression of GR in the developing brain provides a novel
mechanism in the understanding of HIE at the molecular level, and may suggest new
insights for the development of new therapeutic strategies that may be beneficial for the
treatment of newborns with HIE.
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Abstract
Dexamethasone treatment on neonate rat brain has demonstrated neuroprotection
against hypoxic-ischemic brain injury. However, very little is known about this
neuroprotective mechanism. We examined the effect of dexamethasone on the level of
pERK 1/2 and determined the effect of inhibition of LPGDS, DP1 receptor and
MAPK/ERK on the expression of pERK ½ in the presence and absence of
dexamethasone. In total, 116 ten-day old rats were used. Dexamethasone and inhibitors
were administered through intracerebroventricular injections. Effect on the level of pERK
1/2 expression patterns were assessed through western blotting. Prostaglandin D2 levels
were determined by ELISA. HI brain injury volume was determined 48 hours after drug
treatment. Dexamethasone increases the level of pERK-44 in normoxic brains effect that
was repressed by the presence of PD-98059, an inhibitor of MAPK. Dexamethasone also
increases the expression of LPGDS and the levels of PGD2 in the P10 rat brains.
Inhibitors of LPGDS and DP1 receptor also repressed the effect of dexamethasone in the
expression of pERK-44. Moreover, the neuroprotective effect of dexamethasone against
HI-brain injury was blocked by the presence of those inhibitors. Dexamethasone upregulated the level of pERK-44 and the inhibition of the MAPK repressed the
neuroprotective effect of dexamethasone suggesting that the neuroprotective mechanism
of dexamethasone against HI brain injury is associated with the MAPK/ERK pathway,
where LPGDS/PGD cascade plays a significant role.
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Introduction
Glucocorticoids are essential for life and play a crucial role in the regulation of
growth and development. The brain is the major neural target for the action of GCs,
where they bind to intracellular glucocorticoid and mineralocorticoid receptors in neurons
and glia (Abraham, Harkany, Horvath, & Luiten, 2001). GRs are highly expressed in the
developing brain and a neuroprotective role against hypoxia-ischemic injury has been
reported for dexamethasone a synthetic glucocorticoid (Gonzalez-Rodriguez, Xiong, Li,
Zhou, & Zhang, 2014). The neuroprotective effects of GCs may be mediated by distinct
mechanisms involving modulation of Ca2+ currents, enhanced synthesis of lipocortin-1
and neurotrophic factors, and their ability to attenuate lipid peroxidation (Flower &
Rothwell, 1994; Joels & de Kloet, 1994; Mocchetti, Spiga, Hayes, Isackson, &
Colangelo, 1996; Young & Flamm, 1982). However, the mechanism of neuroprotection
for dexamethasone against hypoxia ischemia in neonate rats is not well understood. The
intracellular mitogen activated protein kinase/extracellular signal regulated kinase
signaling pathway is used by neurotrophins, neurotransmitters, and neuropeptides to exert
their neurotrophic and neuroprotective effects by specifically enhancing progenitor cell
proliferation and differentiation, neuronal process growth and regeneration, neuronal
survival, and long-term synaptic remodeling and plasticity (Chen & Manji, 2006; Huang,
Wu, Chen, Manji, & Chen, 2003; Sweatt, 2004).
Prostaglandin D synthase catalyzes the isomerization of PGH2, synthetized by
cyclooxygenase (COX)-2, to produce PGD2 (Smith, Marnett, & DeWitt, 1991; Urade &
Hayaishi, 2000). Two types of PGDS have been purified and characterized; lipocalintype PGDS that was previously known as the brain-type enzyme or glutathioneindependent enzyme, and the hematopoietic PGDS, also known as the spleen-type
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enzyme or GSH-requiring enzymes (Kanaoka & Urade, 2003; A. Nagata et al., 1991).
Lipocalin-type PGDS is a unique bi-functional protein, is the only member of the
lipocalin family with and associated enzymatic activity: the synthesis of prostaglandin D2
in the central nervous system, cardiovascular system and in ocular tissues among
others(Beuckmann et al., 1996; Beuckmann et al., 2000; Eguchi et al., 1997). Moreover,
L-PGDS is an extracellular transporter for lipophilic ligands such as retinoids and tyroids,
retinoic acid and amyloid  peptides (Kanekiyo et al., 2007; Pervaiz & Brew, 1987;
Tanaka et al., 1997). Recently, it has been reported that LPGDS protected against
neuronal cell death due to oxidative stress and HIE (Fukuhara et al., 2012; Taniguchi,
Mohri, Okabe-Arahori, Kanekiyo, et al., 2007). Prostaglandin D2 an arachidonic acid
metabolite, is the most abundant prostaglandin in the brain,(Hertting & Seregi, 1989)
where it regulates sleep, temperature and nociception through two distinct G proteincoupled receptors, DP/DP1 receptor and DP2/CRTH2 (Kabashima & Narumiya, 2003; K.
Nagata & Hirai, 2003). Although PGD2 has been associated with inflammation in
peripheral tissues (Honda et al., 2003), and inhibition of platelet aggregation (Yun,
Ohman, Gill, & Keiser, 1991), in-vitro and in-vivo studies have demonstrated a
neuroprotective role for PGD2 (Liang, Wu, Hand, & Andreasson, 2005; Taniguchi,
Mohri, Okabe-Arahori, Aritake, et al., 2007). In the present study, we examined if the
arachidonic cascade and the MAPK/ERK pathway are part of the neuroprotective
mechanism of glucocorticoids.
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Material and Methods
Experimental Animals
Female Sprague Dawley rats with 10-day-old neonates were purchased from
Charles River Laboratories (Portage, MI). All rats were kept in a room maintained at
24°C, a 12-h light/dark cycle, and provided ad libitium access to normal rat chow and
filtered water. All procedures and protocols were approved by the Institutional Animal
Care and Use Committee of Loma Linda University and followed the guidelines by the
National Institutes of Health Guide for the Care and Use of Laboratory Animals.
To evaluate the neuroprotective mechanism of dexamethasone, inhibitors of
LPGDS (SeCl4, Sigma), MEK1/2 (PD98059, Sigma) and the antagonist of DP1 receptor
(MK-0524, Santa Cruz) were used in presence and absence of dexamethasone. These
were injected into the right lateral ventricle prior to the HI treatment. Pups were
anesthetized and fixed on a stereotaxic apparatus (Stoeling). An incision was made on the
skull surface and bregma exposed. Each reagent or a cocktail was injected at a rate of
1ul/minute with a 10 ul syringe (Stoeling) on the right hemisphere following the
coordinates relative to bregma: 2 mm posterior, 1.5 mm lateral and 3.0 mm below the
skull surface (Li, Gonzalez, & Zhang, 2012). Saline was injected as the vehicle control.
The injection lasted 2 minutes and the needle was kept for additional 5 minutes before its
removal. The incision was sutured, and the animals were allowed to recover on a 37°C
heated blanket. The animals were returned to their dams after recovering from
anesthesia. Dexamethasone and SeCl4 were purchased from Sigma.

Prostaglandin Quantification
Forty-eight hours after dexamethasone was injected to the P-10 pups,
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dexamethasone and control group were decapitated, the amount of PGs in their freshfrozen right hemisphere brain was determined by ELISA (Arnold, 2012), following the
manufacturer’s instruction with slight modification. This kit is based on the conversion of
PGD2 to a stable methoxime derivative by treatment with methoxamine hydrochloride.
Briefly, the right hemispheres were homogenized with 50mM KH2PO4, 5mM EDTA, 43
mM acetylsalicylic acid and pH 7.4 buffer. Homogenate were centrifuged at 13,600 g for
5 min and supernatants stored at -80 ° C. Samples were diluted with cold acetone,
incubated on ice for 5 min and centrifuged at 3,000 rpm for 10 min. Frozen sample were
lyophilized. PGD2 concentration was measured using a PGD-Methoxime EIA kit
(Cayman Chemicals).

Western Blot
Brains were homogenized on an ice-cold lysis buffer containing 20 mM HEPES,
10 mM KCl, 1.5 mM MgCl2, 50 mM Tris-HCl, 10 mM EDTA, 0.1% Tween-20, 0.1% bmercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride, 5 ug/ml leuptin and 5 ug/ml
aprotinin, pH 7.4. Homogenates were centrifuged at 4°C for 10 min at 14,000g, and
supernatants aliquots were collected and stored at -80°C. Protein concentrations were
determined using a protein assay kit from Bio-Rad. Samples with equal protein (40 g)
were loaded on 10% sodium dodecyl sulfate polyacrylamide gel and preformed the
electrophoresis analysis. After electrophoresis, proteins were transferred to nitrocellulose
membranes. Nonspecific binding was blocked in TBST containing 5% dry milk for 60
min at room temperature. The membranes were incubated with rabbit LPGDS, DP1
(1:200; Santa Cruz Biotechnology) and rabbit pERK1/2 (1:1000; Cell Signaling)
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polyclonal antibody overnight at 4°C. The membranes were then washed and incubated
with secondary horseradish peroxidase-conjugated goat anti-rabbit antibody (1:4000;
Santa Cruz Biotechnology, Santa Cruz, CA). Protein bands were visualized with
enhanced chemiluminescence reagents, and the blots were exposed to Hyperfilm (GE
Healthcare). Results were analyzed and quantified by the Kodak electrophoresis
documentation and analysis system with Kodak ID image analysis software. For
comparison of the levels of LPGDS, DP1 and pERK1/2 protein relative density between
the groups, samples were normalized first to -actin values and then presented as fold
values relative to sham-treated animals.

Brain Hypoxic-Ischemic Treatment
Functional studies were performed by inducing brain HI injury in P10 rat pups,
using a modified Rice-Vannucci model, described previously (Gonzalez-Rodriguez et al.,
2014). Briefly, pups were anesthetized with 2% isoflurane, a small incision was made in
the right side of the neck where the right common carotid artery was exposed and ligated
with silk surgical suture. The incision was sutured. After recovery for 1 hour, pups were
treated with 8% O2 for 2 hours. Following 3 hours of recovery, on a warm pad, the pups
were returned to their moms.

Brain Infarction Measurement
Forty-eight hours after HI treatment pups were euthanized and brain infarct size
was determined as previously described (Gonzalez-Rodriguez et al., 2014). Briefly, brain
coronal slices of 2-mm thick were immersed in a 2% solution of 2,3,5-
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triphenyltetrazolium chloride monohydrate (Sigma-Aldrich) for 5 min at 37 °C and then
fixed by 10% formaldehyde overnight. Each slice was weighed, photographed separately
and the percentage of infarction area for each slice was analyzed by Image J software
(Version 1.40; National Institute of Health, Bethesda, MD), corrected by slice weight,
summed for each brain, and expressed as a percentage of whole brain weight.

Statistical Analysis
Data are expressed as mean ± SEM. Experimental number (n) represents neonates
from different dams. Data was analyzed by Student’s t-test using GraphPad Prism
(v5.0a). Values of P < 0.05 were considered as significant.

Results
Brain Protein Levels of pERK 1/2 Affected by Dexamethasone Treatment
To analyze the cell signaling pathway responsible for dexamethasone
neuroprotection, we prepared Western blots with tissue samples form P10 rat brain.
Dexamethasone treatment on P10 rat showed a significant increase of the expression of
pERK-44 (*p<0.05 versus saline; Figure 1) on the brain, while there was no effect of the
dexamethasone treatment on the expression of isoform pERK-42 (*p>0.05 versus saline;
Figure 1A). To demonstrate that the effect on the expression of pERK-44 was associated
with dexamethasone treatment, inhibition of MEKK with PD98059 was evaluated. P10
rats treated with PD98059 showed no effect on the protein expression of pERK-44 after
dexamethasone treatment (*p>0.05 versus PD98059; Figure 1B).
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Prostaglandin D2 Level was Increased by Dexamethasone
We quantified the level of prostaglandin D2 in the brain of P10 rats 48 h after
dexamethasone treatment. The level of PGD2 was significantly increased (*p<0.05
versus control; Figure 2) by the presence of the glucocorticoid. The level of LPGDS was
also determined in the presence of dexamethasone. As shown in Fig. 3 the protein
expression of LPGDS was significantly increased (*p<0.05 versus control) 48 h after
dexamethasone treatment. Figure 4 shows western blot analysis of DP1 receptor on
neonate brains after the dexamethasone treatment. No significant difference was observed
(p>0.05 versus control).

Inhibition of LPGDS and the Effect of Dexamethasone on pERK ½
We examined the effect of dexamethasone on P10 brain rats treated with SeCl4, a
selective inhibitor of LPGDS, in the presence and absence of dexamethasone. The
quantitative analysis of the Western blot is shown in Figure 5A where the expression of
pERK 1/2 is not affected by the presence of dexamethasone (p>0.05 versus SeCl4) when
LPGDS is inhibited by selenium chloride.
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Blocking of DP1 Receptors and the Effect of Dexamethasone on
Protein Level of pERK½
The possible role of prostaglandin D2 in the neuroprotective mechanism of
dexamethasone was evaluated by treatment of MK-0524, a DP1-selective antagonist, in
the presence and absence of dexamethasone in P10 rat brain. Figure 5B shows that the
protein levels of pERK 1/2 were not affected by the presence of dexamethasone (p>0.05
versus MK-0524).

Dexamethasone’s Neuroprotective Role In Vivo is Associated with
pERK Pathway
The HI brain injury model was used to evaluate the neuroprotective pathway
associated with dexamethasone treatment. We applied signal transduction inhibitor
PD98059 into intracerebroventricular space in the presence and absence of
dexamethasone. Figure 6A shows the neuroprotective effect of dexamethasone on the
brain exposed to HI brain injury, 4.56±0.65 (Figure 6Aii) versus 10.95±1.46 (Figure 6Ai)
% infarction (*p<0.05), this neuroprotective effect was repressed by the presence of the
MEKK inhibitor, 16.77±3.00 (Figure 6Aiv) versus 18.47±3.03 (Figure 6 Aiii) %
infarction. Treatment of the inhibitor of LPGDS in the neonate brains reversed the
neuroprotective effect of dexamethasone, 16.38±1.70 (Figure 6Avi) versus 15.10±2.25
(Figure 6Av) % infarction. Similar results were observed when the brains were treated
with the DP1 antagonist, MK-0524 where dexamethasone could not protect against the
HI brain injury, in the presence of the antagonist (18.36±1.34 versus 18.32±0.42 %
infarction, Figure 6Avii and Figure 6Aviii).
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Discussion
The new findings of the present study are: (1) dexamethasone increases
selectively the expression of the isoform of pERK-44 on P-10 neonate brains, (2) the
interaction of arachidonic acid cascade in the neuroprotective mechanism of
dexamethasone and (3) the neuroprotective role of dexamethasone against HI brain injury
is associated with the MAPK/ERK pathway.
Previous studies have demonstrated that maternal hypoxia increase the
vulnerability of the brain to HI injury by repressing the expression of glucocorticoid
receptor. Also, that activation of GRs by dexamethasone reduced the HI-induced brain
injury suggesting a neuroprotective role to GRs (Gonzalez-Rodriguez et al., 2014).
However, the neuroprotective mechanism associated with GRs is not well understood. In
this study we reported that dexamethasone treatment increased the protein expression of
pERK-44, although the same treatment did not affect the expression of pERK-42,
suggesting a selective regulation of pERK-44 by dexamethasone. In vitro studies, where
morphine down-regulated selectively pERK-42 levels with no effect on pERK-44, have
also demonstrated a selective regulation on pERK1/2 (Muller & Unterwald, 2004).
Neonate brains treated with PD98059 repressed the effect of the up-regulation by
dexamethasone, suggesting that pERK-44 could be the isoform of pERK that could
regulate the neuroprotective mechanism of dexamethasone. The downstream part of the
mechanism by which dexamethasone exerts this protective effect is associated with the
blocking of the cascade of events culminating in apoptosis (Ekert et al., 1997). One
pathway could include the phosphorylation of Thr125 in caspase-9, a conserved MAPK
consensus site targeted by ERK2 in vitro, block the caspase-9 processing and subsequent
caspase-3 activation (Allan et al., 2003).
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Lipocalin-type prostaglandin D synthase catalyzes the isomerization of PGH2, a
common precursor of various prostanoids, to produce PGD2, a potent endogenous
somnogen and nociceptive modulator. This enzyme is the most abundant cerebrospinal
fluid protein produced in the brain (Kanekiyo et al., 2007). LPGDS-deficient mice
exhibited an exacerbated phenotype following transient or permanent ischemic brain
injury, indicating a critical role of L-PGDS in protection against cerebral ischemia
(Saleem, Shah, Urade, & Dore, 2009). HIE neonatal brains from human and mouse,
expressed a higher number of L-PGDS-positive cells than in non-HIE neonatal brains,
which were immunoreactive for p53, while some of these expressed cleaved caspase-3
(Taniguchi, Mohri, Okabe-Arahori, Kanekiyo, et al., 2007). It has been demonstrated the
neuroprotective role of PGD2 in vitro (Liang et al., 2005), therefore, it is possible that
LPGDS may protect the neurons by local secretion of PGD2 in HIE brain. Also,
dexamethasone treatment, in mouse neuronal cells, induces LPGDS mRNA and protein
expression (Garcia-Fernandez et al., 2000). In our results dexamethasone treatment
increased the protein levels of LPGDS in neonatal normoxic brains. To evaluate the
possible role of LPGDS in the neuroprotective mechanism of dexamethasone neonate
brains were treated with selenium chloride, and inhibitor for LPGDS, in the presence and
absence of dexamethasone. Our data demonstrated that the effect of dexamethasone on
the expression of pERK 44 was blocked by the presence of the LPGDS inhibitor and also
that the neuroprotective effect of dexamethasone on HI brain injury was repressed by
SeCl4. This data suggest that LPGDS plays a significant role on the neuroprotective
mechanism of dexamethasone toward HI brain injury that includes the activation of the
MAPK/ERK pathway.
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Prostaglandins are up regulated in the ischemic brains (Nogawa, Zhang, Ross, &
Iadecola, 1997) and it has been reported that in mouse PGD2 protects the brain from
hypoxic ischemic injury (Taniguchi, Mohri, Okabe-Arahori, Aritake, et al., 2007). Also
an in-vitro study demonstrated that prostaglandin D2 activated the ERK mitogenactivated protein kinase (Choi et al., 2011). The results from our ELISA study showed
that the levels of prostaglandin D2 increased due to the presence of glucocorticoids.
Moreover, in our functional studies, brain treated with the DP1 antagonist, MK-0524,
demonstrated that the neuroprotective effect of dexamethasone was blocked and at
molecular levels dexamethasone has none effect in the expression of pERK 1/2. Our
results suggested that dexamethasone increased the level of prostaglandin D2 that
eventually induced neuroprotection through the DP1 receptor by activating the
downstream kinase ERK 1/2 which is involved in the PGD2-DP-mediated
neuroprotection. Interestingly, it has been reported that PGD2 exerted cardioprotective
effect by binding to the DP receptor being ERK 1/2, the major downstream pathway, due
to the presence of glucocorticoids (Tokudome et al., 2009).
Perinatal HI is a major cause of death and disability worldwide which has been
limited to supportive intensive care. Although there are advances in research of cellular
processes and molecular mechanism, hypothermia is the only treatment effective in
neonatal HIE at present. The combination of hypothermia with neuroprotective
treatments looks to be promising in a way to improve the neurological outcome of HI. In
this study we demonstrated that the neuroprotective effect of dexamethasone on neonate
HI brain injury is associated with the pathway of MAPK/ERK and that LPGDS/PGD
cascade plays a significant role in this glucocorticoid neuroprotective mechanism. Future
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studies related to the selective regulation of dexamethasone on the production of pERK44
needs to be done and the possibility that pERK44 could play a neuroprotective role needs
to be elucidated. The downstream neuroprotective mechanism of glucocorticoids, that are
associated with apoptosis, seems like a very fertile area that could be explored to find a
novel treatment against neonates HI brain injury.
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CHAPTER FIVE
GENERAL DISCUSSION

Certainly the habits generated by humans such as consuming healthy food, having
a good exercise routine, smoking, or drinking induces a clear influence in an excellent or
detrimental health life. However the environmental area can also play a significant role.
One environmental area that has generated more interest is the environment to which the
fetus is exposed to during development and how the fetus has to adapt to that
environment that can compromise the development of some organs and ultimately
increase the risk to certain conditions or diseases during adulthood. This interest began
with the study presented by Barker, who shows that birth weight is inversely proportional
to the risk of cardiovascular disease and hypertension in adulthood. This was the
foundation for what is known today as the theory of developmental of health and disease
(Barker, 2007). Different studies have been supporting this theory, where birth weight
has a strong correlation with risk of developing cardiovascular (Barker & Osmond,
1986), metabolic (Hales & Ozanne, 2003), kidney, and lung (Gluckman, Hanson, Cooper,
& Thornburg, 2008) disease among others. This low birth weight has been associated
with some maternal perturbation as calorie and protein restriction (Lillycrop, Phillips,
Jackson, Hanson, & Burdge, 2005), placental insufficiency (Pham et al., 2003), exposure
to glucocorticoids (O'Sullivan et al., 2013) that induce a harsh environment and program
adult onset disease. Our study demonstrated that perinatal hypoxia affected the
development of the kidney by inducing aberrant expression of angiotensin II receptors
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and accelerating the aging process of the kidney. Furthermore we demonstrated that
perinatal hypoxia affected the development of the brain by increasing the vulnerability in
neonates to hypoxic-ischemic brain injury, by repressing the expression of glucocorticoid
receptors.

Effect of Hypoxia in Kidney Development
A hypoxia environment, on pregnant rats during their last week of pregnancy,
affected the kidney organogenesis of the fetus. As has been mentioned, low birth weight
is associated with programming diseases and perinatal hypoxia not just affecting the body
weight of the E21 and P7 rats, but also affecting the kidney weight in an asymmetrical
manner, suggesting that this adverse environment affects the development of the kidney.
However for the 3M adult rats there was no difference between the control and the
hypoxia treated group suggesting a “catch-up” process. Similar results were observed
using maternal undernutrition and this acceleration during postnatal growth is a trigger
for development of detrimental health life during adulthood (Lai et al., 2004).
As we reported, maternal hypoxia decreases the number of nephrons,
oligonephronia, on P7 and 3M rat offspring. It is known that any adverse event occurring
before completion of nephrogenesis likely compromises renal growth and produces a
longer lasting effect on final renal function (Gray, Denton, Cullen-McEwen, Bertram, &
Moritz, 2010). The nephrons are the structure in the kidney that induces the renal
secretory and reabsorption functions; they filter the blood and also regulate the blood
pressure among other functions, which means that a reduction in the number of nephrons
could be detrimental. There is a hypothesis that states that a lower number of nephrons
will decrease the surface area of filtration and this will lead to an increase in the
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glomerular pressure and eventually will induce hypertension. A reduction number of
nephrons due to uninephroctomy during the first 24 h after birth leads to increased blood
pressure in adult rats (Woods, 1999). Additionally, evidence using animal models has
shown that adverse environment during pregnancy as alcohol intake or a high salt diet
induced oligonephronia in the offspring and increased their blood pressure during
adulthood (Gray et al., 2010; Woods, Weeks, & Rasch, 2004), suggesting this, that
programming hypertension due to maternal hypoxia could be observed due to the
oligonephronia found in the offspring.
The oligonephronia observed during adulthood showed sexual dimorphism
because, even though the effect was observed on both genders, the reduction on female
(58%) was higher than the observed by the males (26%) suggesting that there is a genderspecific programming in the aberrant kidney development against the females.
Interestingly, in a study using maternal protein restriction the male exhibited
oligonephronia, while this event was not observed in female, demonstrating a sexual
dimorphism effect against the males (Woods, Ingelfinger, Nyengaard, & Rasch, 2001;
Woods, Ingelfinger, & Rasch, 2005). It will be interesting to evaluate the possible effects
of adverse environment on gender hormones that could eventually result in sexual
dimorphism of programming diseases. For example it is known that lung maturation for
female fetuses during fetal development is faster than in male fetuses and this difference
is apparently due to the presence of estrogen in the females that induces stimulatory
effects (Patrone et al., 2003).
Otherwise, the Renin-Angiotensin System is both a circulating and tissue/organ
specific hormonal system implicated in various physiological and pathophysiological
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processes via the major peptide angiotensin II stimulating its specific AT1R and AT2R,
which demonstrate opposite effects in many conditions (Dasgupta & Zhang, 2011; Sokol
et al., 2004). In our study we evaluate the effect of maternal hypoxia environment in the
expression of AT1R and AT2R on the offspring. This maternal insult has no effect on the
protein abundance of both receptors in either fetal or neonatal rats as compared with
normoxic animals. However, there was significant difference between both groups in the
adult offspring for the AT1R while no difference was found in the protein abundance of
AT2R. Moreover the maternal hypoxia also decreases the mRNA abundance of AT1aR
and AT1bR in the kidney of the offspring. Nevertheless, a study using maternal nicotine
showed that this maternal insult has no effect on the expression of AT1R in rat kidney in
three post-natal stages of the offspring, including adult, while the expression of AT2R
was decreased in all three post-natal stages (Mao et al., 2009). This may suggest that
different maternal insults affect the organogenesis of the kidney in different ways.
Also, the RAS is of crucial importance during fetal development as angiotensin II
acts as a potent growth factor in nephrogenesis (Woods et al., 2001). One role for
angiotensin II during nephrogenesis is stimulating the branching of the ureteric bud by
down-regulating the Sprouty 1 protein, which inhibits the receptor tyrosine kinase
signaling, this effect will activate the GDNF/c-Ret/Wnt11 pathway that will eventually
lead to the branching of the ureteric bud and eventually the formation of the nephrons
(Yosypiv, Boh, Spera, & El-Dahr, 2008). Recently, studies suggested that maternal
insults suppresses the renin-angiotensin system of newborns, reduced the number of
glomeruli and leads to hypertension during adulthood (Woods et al., 2001). Our study
demonstrated no effect of maternal hypoxia in the RAS of fetus or neonates rats, but we
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observed an aberrant development of the kidney due to a decrease on the number of
nephrons on neonates and adult offspring. Nephrogenesis is controlled partly by RAS but
there are other factors that are associated with the kidney development that could be
affected by maternal hypoxia to induce the oligonephronia observed in our work. One
possible mechanism that could be explored is Wnt4 that is needed for the differentiation
of the metanephric mesenchyme into nephron epithelia (Stark, Vainio, Vassileva, &
McMahon, 1994), or evaluate the effect of maternal hypoxia on the fibroblast growth
factor-2 (Karavanova, Dove, Resau, & Perantoni, 1996) and on the transforming growth
factor -2 (Sanford et al., 1997), which are capable of inducing nephrogenesis. The
retinoid receptors might be another potential target for maternal hypoxia because they
mediate the remodeling process of epithelial cells associated with nephrogenesis
(Batourina et al., 2001).
Finally, we observed that perinatal hypoxia decreased the number of glomeruli on
offspring adult rats as compared with the normoxic group. The aging process in human
kidney is associated with reduction of glomerular filtration rate, segmental glomerular
sclerosis and reduction in the number of glomeruli (Epstein, 1996). Our findings not only
suggest that perinatal adverse environment affected the kidneys in an aberrant way but
also that this early hostile event could accelerate the kidney aging process.

Effect of Hypoxia on the Vulnerability of the Brain to Neonatal
HIE
One of the advantages that perinatal studies offer is that they can give us some
light of the pathogenesis of diseases and eventually lead us to develop some kind of
treatment against those conditions. With this in mind we evaluate the effect of maternal

109

hypoxia in brain development of the rat offspring and how this insult affects the
vulnerability of the brain against hypoxia-ischemic brain injury. Consistent with results
reported in our kidney studies, maternal hypoxia affected the body weight of the fetus but
also the weight of the brain in an asymmetrical pattern. Interestingly, when we compare
the organ/body weight ratio for the brain and kidney, the ratio observed for the kidneys,
which were exposed to maternal hypoxia, is lower than the control group; however the
ratio observed for the brains that were exposed to hypoxia, was higher than for those
brains of the normoxic group. This result may be in agreement with the concept that if
the fetal body experiences a decrease in the level of delivered oxygen there will be a
decrease of the amniotic fluid and a redistribution of fetal blood flow with a decrease in
perfusion to the kidney and an increase of perfusion to the brain, heart and liver. The
“catch-up” event was also observed in this study where the hypoxic fetus rats have a
lower body and brain weight as compared to the normoxic fetuses but these differences
were not observed in the P10 pups of both groups, and as mentioned before this could
have long-term detrimental effects for the hypoxic neonates.
In chapter three we reported that maternal hypoxia increases the vulnerability of
the brain toward neonatal hypoxic-ischemic encephalopathy by a mechanism that
involved the repressing of the expression of glucocorticoid receptors. In the following
section we will be discussing other possible mechanisms that could increase the
vulnerability of the brain to HIE.

Mechanisms That Could be Involved in Fetal Stress-Mediated
Increase in The Susceptibility of Neonatal HIE
The renin-angiotensin system could be a target for maternal insult where the

110

susceptibility of neonatal toward HIE is increased by reprogramming the expression
patterns of the RAS in the brain (Mao et al., 2009). The action of the RAS is by the
activation of AT1R and AT2R by angiotensin II, and it is known that RAS is a circulating
and tissue/organ specific hormonal system implicated in various physiological and
pathophysiological processes (Dasgupta & Zhang, 2011; Shi, Mao, Xu, & Zhang, 2010;
Sokol et al., 2004). In the brain the presence of both AT1R and AT2R can be found during
different developmental stages with different expression patterns and signaling pathways.
The importance of RAS in the development and evolution of cerebrovascular diseases has
been reported in clinical trials and experimental studies with mature brains. LIFE and
MOSES are examples of clinical trials that have been shown that by blocking the RAS it
demonstrated neuroprotection with the prevention of first of recurrent strokes in high-risk
populations, independent of its blood pressure-lowering effect (Lindholm et al., 2002;
Schrader et al., 2005). Anti-apoptotic, anti-inflammatory, anti-oxidant effects can be
observed in studies with AT1R antagonist which improve cerebral perfusion,
demonstrating vascular-dependent and -independent neuroprotection in acute stroke
(Ando, Zhou, Macova, Imboden, & Saavedra, 2004; Dai, Funk, Herdegen, Unger, &
Culman, 1999; Lou et al., 2004; Zhou, Ando, Macova, Dou, & Saavedra, 2005).
Although very little is known about the role of AT2R in neurological pathophysiology,
evidence has been found that demonstrated the beneficial effect of AT2R in a variety of
pathologies including various neurological conditions. The neuroprotective role of AT2R
was suggested when this receptor was up regulated in the brain, mostly in the ischemic
area during stroke (Mogi et al., 2006), besides increased activation of AT2R may be
responsible for some neuroprotective effects of AT1R antagonism (Li et al., 2005). In
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vitro stimulation of AT2R promotes intense neurite outgrowth, which can be antagonized
by PD123319 (Laflamme, Gasparo, Gallo, Payet, & Gallo-Payet, 1996). Additionally, in
a rat model of stroke, a direct stimulation of AT2R with CPG42112 induced a
neuroprotective effect that was beyond blood pressure regulation (McCarthy, Vinh,
Callaway, & Widdop, 2009). The underlying mechanisms of AT2R in neuroprotection
remain to be elucidated. Some studies indicated that it might be related to its complicated
interaction with AT1R in apoptotic modulation, neuronal regeneration and vasodilation in
ischemic regions following stroke (Jones, Vinh, McCarthy, Gaspari, & Widdop, 2008;
Saavedra, Benicky, & Zhou, 2006).
Fetal stress may also reprogram expression patterns of matrix metalloproteinase in
the neonatal brain, which contribute to the enhanced vulnerability of HIE. MMPs belong
to a family of zinc-dependent proteases that exert pronounced effects in the ECM
turnover. These enzymes remodel almost all components of the matrix and play an
essential role in cell signaling regulation, cell survival and cell death. MMPs, especially
MMP-2, MMP-3 and MMP-9, may target the extracellular matrix of blood vessels, basal
lamina, and tight junctions in endothelial cells, increase the permeability of the bloodbrain barrier in neuroinflammation due to hypoxia-ischemia, multiple sclerosis and CNS
infection, which can result in cytotoxic and vasogenic edema, promote hemorrhagic
transformation, induce apoptosis of neurons and oligodendrocytes (Cunningham, Wetzel,
& Rosenberg, 2005; Rosenberg, 2009). However, in later stage of such pathology, MMPs
play critical roles in tissue repair and remodeling process via inducing angiogenesis and
neurogenesis. Growing evidence suggests that overly up-regulated activity/expression of
MMPs, particularly MMP-2 and MMP-9, is deleterious in the acute phase of stroke.
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Inhibition of MMPs in the acute phase may reduce the damage to BBB (Gasche, Copin,
Sugawara, Fujimura, & Chan, 2001). There is a report indicating decreased damage to
BBB and reduced infarct size in a focal ischemic MMP-9 knockout model (Asahi et al.,
2001). More importantly, a recent study in a neonatal rat HIE model revealed that early
inhibition of MMPs conferred acute and long-term beneficial effects via reducing tight
junction proteins degradation, attenuating the permeability of BBB, improving brain
edema, and preventing brain atrophy (W. Chen et al., 2009). Fetal hypoxia reprograms
expression patterns of MMPs in the heart and brain and increases activities/expressions of
both MMP-2 and MMP-9 in the neonatal brain (Tong et al., 2010; Tong, Xue, Li, &
Zhang, 2011; Tong & Zhang, 2012). Considering the evident detrimental effects of
MMPs in the acute stroke models and other neurological pathophysiologies, it is
plausible that altered expression patterns of MMPs by prenatal stress are other important
mediators in programming of ischemic-sensitive phenotype and increased susceptibility
of HIE in the neonatal brain.

Epigenetic Mechanisms in Fetal Programming
In our study we found that the expression of the glucocorticoid receptors was
repressed due to hypermethylation in the promoter region of the GR due to maternal
hypoxia. One of the important adaptive mechanisms that the human body could be
evoked to react to some adverse environments is through epigenetic modification of gene
expression patterns. The fetal developmental stage is the most critical period for the
human being because in the uterus the fetus can be exposed to inadequate or
inappropriate environments that could be chemical/ nutritional or non-chemical. These
epigenetic changes could be associated with conditions or diseases during adulthood.
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The fetus is a critical developmental stage in which different events occur in a
way to induce repression or activation of gene transcription via epigenetic mechanisms
(M. Chen & Zhang, 2011). Brain-derived neurotrophic factor plays a vital role in the
brain development. An epidemiologic study in adolescents whose mothers smoked during
pregnancy revealed that prenatal nicotine exposure increases DNA methylation of the
BDNF-6 exon, and this may lead to changes in the plasticity and development of the
brain (Toledo-Rodriguez et al., 2010). A recent study evaluated the DNA methylation
patterns of the genes coding GR, 11b-HSD2, neuronatin and reelin in hippocampus of the
offspring rats from pregnant animals that had been treated with a deficient methyl donor
diet. Though the behavior differences were demonstrated between MDD and the control
groups, the DNA methylation patterns of these genes were not altered (Konycheva et al.,
2011). However, it has been shown that maternal stress of pregnant rats during
gestational days 12–16 increases the levels of DNA methylation in frontal cortex and
hippocampus in offspring, which is associated with behavioral changes in offspring rats
(Mychasiuk, Ilnytskyy, Kovalchuk, Kolb, & Gibb, 2011). Additionally, it has been found
that fetal exposure to bisphenol A (BPA), a xenoestrogen, induces changes in DNA
methylation patterns in the 2500 Notl loci, suggesting that the maternal BPA exposure
may also exert some programming effects on brain development (Yaoi et al., 2008).
Recently, there has been increased interest to evaluate the effect of maternal
environment on other epigenetic modifications that could lead to programming diseases.
Synthetic glucocorticoids are used during pregnancy to support the maturation of fetal
organs. Though the exposure to sGC during fetal development has resulted detrimental,
inducing endocrine and metabolic abnormalities in animal offspring. Moreover it has

114

been reported that fetal exposure to sGC resulted in substantial differences in the
acetylation of histone h3 lysine 9, in specific gene promoters (Crudo et al., 2013). In a rat
model of low protein diets it was demonstrated that this maternal environment repressed
the expression of the liver X receptor  and also decreased the acetylation of H3K9 and
H3K14 which surrounds the transcriptional start site of Lxr. The down regulation of this
receptor leads to impaired glucose tolerance in the offspring (Vo, Revesz, Sohi, Ma, &
Hardy, 2013). Maternal smoking during fetal development increases the risk of
overweight to the offspring (Weng, Redsell, Swift, Yang, & Glazebrook, 2012). In a rat
model, elevated levels of triglycerides were found in the circulation and liver of the
offspring, associated with maternal nicotine. The synthesis of triglycerides is catalyzed
by the fatty acid synthase, which was up-regulated due to maternal nicotine. The FAS is
regulated by Lxrthe expression of this receptor was also up-regulated and associated
with an hyperacetylation of H3K9 and H3K14 which are close to the FAS promoter (Ma,
Nicholson, Wong, Holloway, & Hardy, 2014).
Another fetal stress associated with histone modification is maternal caffeine
intake. This type of insult inhibited the production of adrenal corticosterone in fetus. The
expression of StAR, which is an enzyme associated with corticosterone production, was
down-regulated in the rat fetal adrenal due to maternal caffeine consumption (Ping et al.,
2014). This stress also affects the histone acetylation of the SF-1 promoter, which is a
key transcription factor for StAR. The decreased in the acetylation levels of H3K9 and
H3K14 in the promoter region of SF-1 was associated with the down-regulation of StAR.
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Potential Neuroprotective Mechanism Against HIE
In chapter three we suggested a neuroprotective mechanism for glucocorticoid
receptors against HIE. Our study implied that dexamethasone induced L-PGDS
expression, preferentially promoted PGD2 biosynthesis in the developing brain, which
acted as a local mediator in an autocrine and/or paracrine manner to confer protective
effects via chiefly interaction with DP1 receptor. Another finding of that study is; that
pERK-44 acted as the major downstream effector in dexamethasone pretreatment
mediated neuroprotection in neonatal HI brain injury (Figure 1). Apoptosis is one of the
cell death mechanism found on HI brain injury. It is well known that activation of
ERK/MAPK is associated with cell survival by increasing the expression of Bcl-2, which
repress the activity of caspase 3 resulting in a decrease of apoptosis level. Further
experimentation into this mechanism in our HIE model will help to increase our
knowledge on the neuroprotection mechanism of dexamethasone. Also in this section we
are going to discuss some other potential neuroprotective mechanisms. A possible
neuroprotective role against HIE has been suggested for the delta opioid receptors. In a
model of asphyxia cardiac arrest, the activation of DOR by the specific agonist [d-Ala2,
d-Leu5] encephalin induced neuronal survival, neuroprotective effect that was reversed
by Naltrindole, an antagonist for DOR (Gao et al., 2010). DADLE also show
neuroprotection by inducing neuron survival in astrocytes of the hippocampal CA1
region after global cerebral ischemia (Duan et al., 2011). During an event of HIE the
ATP-dependent Na+-K+ pumps are impaired. This may result in an influx of Na+ and a
leak of K+, which is detrimental for the cell.
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Death

Figure 1. Proposed signaling pathway in dexamethasone pretreatment induced neuroprotection against
neonatal hypoxic-ischemic brain injury. GR indicates glucocorticoids receptor; L-PGDS indicates
lipocalin-type prostaglandin D synthase; PGH2 indicates prostaglandin H2; PGD2 indicates prostaglandin
D2; DP1 indicates D prostanoid; MEK1 indicates mitogen-activated kinase/ERK kinase 1; pERK-42/44
indicates phosphorylated extracellular signal regulated kinase 42/44; SeCl 4 indicates selenium chloride, a
selective inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS); PD98059, selective inhibitor of
MEK1; MK-0524, a selective antagonist for prostaglandin D2 receptor (DP1); HI indicates hypoxicischemic; Bcl-2 indicates B-cell lymphoma 2; p38 indicates.
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The activation of DOR in an anoxic model decreased the K+ leakage and also the Na+
influx in cortical neurons (Chao, Balboni, Lazarus, Salvadori, & Xia, 2009). Moreover,
HIE is characterized by mitochondrial dysfunction. In a study with cultured cortical
neurons, sodium azide inhibited the mitochondrial respiratory chain, inducing brain
injury that was reduced by the activation of DOR. This neuroprotective effect was
inhibited by NTI (Zhu et al., 2009).
Another possible neuroprotective mechanism against HIE is the cannabinoid
receptor type 1. The CB1 receptors are G protein-protein coupled receptors that could be
located in the basal ganglia, amygdale, cerebellum, hippocampus, cerebral cortex and in
the hypothalamus as well as in tissues from other organs (Galiegue et al., 1995). Another
detrimental effect of HIE is the generation of nitric oxide by the nitric oxide synthase.
The activation of CB1 in brain microglial cells of rats, inhibit the NO production (Cabral,
Harmon, & Carlisle, 2001). Rat brain slices were exposed to oxygen-glucose deprivation
for 30 min that resulted in an increase of glutamate and TNF-. By the activation of CB1
neuroprotective effect was observed, the production of glutamate and TNF- was
inhibited, however, when an antagonist of CB1 was used the neuroprotective effect was
diminished, suggesting that the neuroprotective effect was mediated by CB1 (FernandezLopez et al., 2006). The activation of CB1 also reduced the infarct volume after global
and focal cerebral ischemia and protected cultured cerebral cortical neurons that were
exposed to hypoxia and glucose deficiency (Nagayama et al., 1999).
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Conclusion
The fetal development period is still the most critical experience for the human
being. In this work we demonstrated how, during this event, maternal stress could lead to
some aberrant organogenesis in the fetus and eventually programming the offspring to an
increase risk of disease vulnerability. We demonstrated in this work that maternal
hypoxia, one of the most common adverse environments experienced by fetus, affects the
fetal growth and development of the kidney and the brain of the offspring. This IUGR
induces low weight birth on the neonates a common effect that has been found in the
process of programming diseases. The structure of the kidney was affected by the
maternal insult, where a lower number of glomeruli were observed for the hypoxic
offspring where females were more affected than the males during adulthood, resulting in
a sex dimorphism effect. Additionally, at molecular level maternal hypoxia induced an
aberrant development by affecting the normal expression of AT1R. These observations
suggested that fetal hypoxia, cause an aberrant development of the kidney and accelerate
the aging process during postnatal development that could increase the risk to
cardiovascular diseases during adulthood.
The brain development was also affected by this maternal insult where the
vulnerability toward HIE was increased due to this harmful fetal environment. Moreover
it was demonstrated that maternal hypoxia affected the expression of the glucocorticoid
receptors for which a neuroprotective role against neonate HIE brain injury was found.
The down-regulation of the GR was associated to a hypermethylation event observed in
the promoter region of the GR gene, suggesting that maternal environment could affect
the organogenesis of the brain by inducing epigenetic changes in the fetus genome.
Finally the mechanism of the neuroprotective action of GR was evaluated, where the
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activation of the MAPK/ERK pathway, by dexamethasone, was observed. Moreover,
dexamethasone increases the expression of LPGDS and the levels of PDG2, where the
inhibition of LPGDS and blockade of DP1 receptor represses the neuroprotective role of
DEX. These results suggest that LPGDS/PGD cascade plays a significant role in the
neuroprotective mechanism of GR.
These novel findings provide evidence that maternal environment could affect the
fetal development including the organogenesis of the brain and the kidney. The
possibility that maternal hypoxia increased the risk to HIE provide a mechanistic
understanding that could be evaluated in human. The findings that the repression of the
GR was mediated by this fetal stress and that glucocorticoid activates the MAPK/ERK
pathway with LPGDS/PGD cascade playing a significant role, provides a novel
mechanism in the understanding of HIE at molecular level and suggests new insight for
development of new therapeutic strategies against neonate HIE.
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